chr19:45409053:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr19:45,409,053-45,412,650 |
hg38 | chr19:44,905,796-44,909,393 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
<0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
0.003 | Cardiomyopathy, Dilated | NA | BeFree,GAD | Detail | |
0.243 | Cardiovascular Diseases | We included 210 consecutive patients with late-onset AD to investigate whether e... | BeFree,CTD_human,GAD,LHGDN | 24596166 | Detail |
0.243 | Cardiovascular Diseases | The role of apolipoprotein E in neurodegeneration and cardiovascular disease. | BeFree,CTD_human,GAD,LHGDN | 24754513 | Detail |
0.243 | Cardiovascular Diseases | The apoE polymorphism affects the serum lipoprotein levels, and the ESRD patient... | BeFree,CTD_human,GAD,LHGDN | 25155022 | Detail |
0.243 | Cardiovascular Diseases | The APOE gene stands out as an exception, given that it has been identified as b... | BeFree,CTD_human,GAD,LHGDN | 25159268 | Detail |
0.243 | Cardiovascular Diseases | SN gene therapy exerts beneficial effects in cardiovascular animal models in Apo... | BeFree,CTD_human,GAD,LHGDN | 25377726 | Detail |
0.243 | Cardiovascular Diseases | The present meta-analysis confirms that, besides its previously documented influ... | BeFree,CTD_human,GAD,LHGDN | 25385258 | Detail |
0.243 | Cardiovascular Diseases | The results presented demonstrate that the association between ApoE gene and CVD... | BeFree,CTD_human,GAD,LHGDN | 25413697 | Detail |
0.243 | Cardiovascular Diseases | Our findings provide the scientific rationale supporting a novel clinical applic... | BeFree,CTD_human,GAD,LHGDN | 25731628 | Detail |
0.243 | Cardiovascular Diseases | The analysis showed that Braak stages III to VI were significantly predicted by ... | BeFree,CTD_human,GAD,LHGDN | 26469248 | Detail |
0.138 | Carotid Artery Diseases | NA | BeFree,CTD_human,GAD | Detail | |
0.002 | carotid artery thrombosis | NA | GAD | Detail | |
0.130 | carotid stenosis | NA | BeFree,CTD_human,GAD | Detail | |
0.002 | Chronic Kidney Diseases | The Chi-square test, multivariable logistic regression analysis with adjustment ... | BeFree | 19424605 | Detail |
0.002 | cellulitis | NA | GAD | Detail | |
0.004 | CNS disorder | NA | BeFree,GAD | Detail | |
0.007 | intracranial aneurysm | NA | BeFree,GAD | Detail | |
0.012 | intracranial arteriosclerosis | NA | GAD,LHGDN | Detail | |
0.029 | cerebral infarction | Association of the ApoE gene polymorphism and dietary factors with cerebral infa... | BeFree,GAD,LHGDN | 25730003 | Detail |
0.062 | brain ischemia | NA | BeFree,GAD | Detail | |
0.087 | Transient ischemic attack | NA | BeFree,GAD,RGD | Detail | |
0.011 | cerebral palsy | Our findings suggest that genetic variations in one of the sequences regulating ... | BeFree,GAD | 24786335 | Detail |
0.036 | Cerebrovascular Disorders | NA | GAD,LHGDN | Detail | |
<0.001 | Primary biliary cirrhosis | NA | BeFree | Detail | |
0.025 | cholelithiasis | NA | BeFree,GAD | Detail | |
<0.001 | cholera | NA | BeFree | Detail | |
0.002 | intrahepatic cholestasis | NA | GAD | Detail | |
0.002 | chorioamnionitis | NA | GAD | Detail | |
0.002 | Choroid Diseases | NA | GAD | Detail | |
0.002 | Chromosome Aberrations | NA | GAD | Detail | |
0.125 | Cognition Disorders | NA | BeFree,CTD_human,GAD | Detail | |
0.003 | ulcerative colitis | APOE genotyping was performed to evaluate the allele and genotype frequencies in... | BeFree,GAD | 25624723 | Detail |
0.005 | Colonic Neoplasms | NA | GAD | Detail | |
0.001 | colorectal carcinoma | NA | BeFree | Detail | |
0.012 | Colorectal Neoplasms | Apolipoprotein E polymorphism and colorectal neoplasm: results from a meta-analy... | BeFree,GAD,LHGDN | 25029444 | Detail |
<0.001 | Communication impairment | NA | BeFree | Detail | |
0.005 | Confusion | NA | GAD | Detail | |
0.006 | Febrile Convulsions | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Corneal Diseases | NA | BeFree | Detail | |
0.069 | Coronary Arteriosclerosis | Common variants of apolipoprotein E and cholesteryl ester transport protein gene... | BeFree,GAD | 24402318 | Detail |
0.069 | Coronary Arteriosclerosis | A systematic review and meta-analysis of 130,000 individuals shows smoking does ... | BeFree,GAD | 25173947 | Detail |
0.069 | Coronary Arteriosclerosis | Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it co... | BeFree,GAD | 25333200 | Detail |
0.069 | Coronary Arteriosclerosis | Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ ... | BeFree,GAD | 25377726 | Detail |
0.069 | Coronary Arteriosclerosis | Review: Apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in... | BeFree,GAD | 26142535 | Detail |
0.260 | Coronary heart disease | Common variants of apolipoprotein E and cholesteryl ester transport protein gene... | BeFree,CTD_human,GAD,LHGDN | 24402318 | Detail |
0.260 | Coronary heart disease | A systematic review and meta-analysis of 130,000 individuals shows smoking does ... | BeFree,CTD_human,GAD,LHGDN | 25173947 | Detail |
0.260 | Coronary heart disease | Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it co... | BeFree,CTD_human,GAD,LHGDN | 25333200 | Detail |
0.260 | Coronary heart disease | Review: Apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in... | BeFree,CTD_human,GAD,LHGDN | 26142535 | Detail |
<0.001 | Crohn Disease | APOE genotyping was performed to evaluate the allele and genotype frequencies in... | BeFree | 25624723 | Detail |
0.002 | Cross Infection | NA | GAD | Detail | |
0.003 | Cytomegalovirus Infections | NA | BeFree,GAD | Detail | |
0.003 | Cessation of life | NA | LHGDN | Detail | |
<0.001 | Deglutition Disorders | As neurodegenerative processes are implicated in swallowing dysfunction, we hypo... | BeFree | 24261350 | Detail |
0.019 | Delirium | NA | BeFree,GAD,LHGDN | Detail | |
0.001 | Delusions | NA | BeFree | Detail | |
<0.001 | Multi-infarct dementia | NA | BeFree | Detail | |
0.080 | Presenile dementia | Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late li... | BeFree | 23883793 | Detail |
0.080 | Presenile dementia | High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorder... | BeFree | 23978325 | Detail |
0.080 | Presenile dementia | The presence of apraxia in AD is related to dementia severity and APOE ε4. | BeFree | 24603451 | Detail |
0.080 | Presenile dementia | To explore apolipoprotein E gene variants distribution among the patients of Alz... | BeFree | 24678786 | Detail |
0.080 | Presenile dementia | Results indicate that the relationship between sedentary time and CBF in the lef... | BeFree | 24685629 | Detail |
0.080 | Presenile dementia | The MCI subjects who developed dementia were more likely to carry at least one c... | BeFree | 24685632 | Detail |
0.080 | Presenile dementia | Association of apolipoprotein E-e4 and dementia declines with age. | BeFree | 24731780 | Detail |
0.080 | Presenile dementia | The cluster-derived normal group had significantly fewer APOE ε4 carriers and fe... | BeFree | 24857234 | Detail |
0.080 | Presenile dementia | Apolipoprotein E ε4 (APOE ε4) is a risk factor for β-amyloid deposition in Alzhe... | BeFree | 24985533 | Detail |
0.080 | Presenile dementia | The levels of miR‑193b, exosomal miR‑193b, Aβ, tau, p‑tau, HCY and APOE in sampl... | BeFree | 25119742 | Detail |
0.080 | Presenile dementia | Cognitively healthy NDFAM showed a higher net cognitive gain after CS, as reflec... | BeFree | 25187003 | Detail |
0.080 | Presenile dementia | Increased WMH volume was associated with increased frequency of dementia irrespe... | BeFree | 25304991 | Detail |
0.080 | Presenile dementia | We assessed relative telomere length and apolipoprotein E genotype in subjects w... | BeFree | 25440562 | Detail |
0.080 | Presenile dementia | Influence of socio-demographic features and apolipoprotein E epsilon 4 expressio... | BeFree | 25466513 | Detail |
0.080 | Presenile dementia | We included 209 consecutive late-onset AD patients to find out which factors amo... | BeFree | 25591674 | Detail |
0.080 | Presenile dementia | Apolipoprotein E (APOE) ε4 is an established risk factor for cognitive decline a... | BeFree | 25599330 | Detail |
0.080 | Presenile dementia | Mediation analysis was used to estimate the direct and indirect effects of APOE ... | BeFree | 25623662 | Detail |
0.080 | Presenile dementia | There was a synergistic interaction between depression or apathy and APOE ε4 in ... | BeFree | 25653291 | Detail |
0.080 | Presenile dementia | This article considers APOE ϵ4 effects on cognition in people without dementia, ... | BeFree | 25711453 | Detail |
0.080 | Presenile dementia | The allele frequency of APOE ε4 varies both across and within populations, and t... | BeFree | 25738563 | Detail |
0.080 | Presenile dementia | Subgroup analyses indicated that (1) the significantly increased risk of AD from... | BeFree | 25763939 | Detail |
0.080 | Presenile dementia | We have also established novel methods to express apoE isoforms in mouse brain t... | BeFree | 25871773 | Detail |
0.080 | Presenile dementia | Among persons without dementia, the prevalence of cerebral amyloid pathology as ... | BeFree | 25988462 | Detail |
0.080 | Presenile dementia | These findings indicate the potential clinical utility of amyloid imaging for di... | BeFree | 25988463 | Detail |
0.080 | Presenile dementia | Eleven patients with dementia had apolipoprotein E 4 (ApoE4) and R47H genotypes. | BeFree | 26076170 | Detail |
0.080 | Presenile dementia | Interaction of Apolipoprotein E Genotypes, Lifestyle Factors and Future Risk of ... | BeFree | 26088392 | Detail |
0.002 | Senile dementia | NA | BeFree | Detail | |
0.049 | Mental Depression | There was a synergistic interaction between depression or apathy and APOE ε4 in ... | BeFree,GAD | 25653291 | Detail |
0.049 | Mental Depression | Association between apolipoprotein E gene polymorphism and depression. | BeFree,GAD | 25979253 | Detail |
0.016 | depressive disorder | There was a synergistic interaction between depression or apathy and APOE ε4 in ... | BeFree | 25653291 | Detail |
0.016 | depressive disorder | Association between apolipoprotein E gene polymorphism and depression. | BeFree | 25979253 | Detail |
0.003 | Dermatomycoses | NA | LHGDN | Detail | |
0.011 | Diabetes | These results suggest that previous findings of an association of the TOMM40 sho... | BeFree | 25044051 | Detail |
0.032 | diabetes mellitus | These results suggest that previous findings of an association of the TOMM40 sho... | BeFree,GAD | 25044051 | Detail |
0.032 | diabetes mellitus | Among black APOE ε4 carriers, the strongest predictors of cognitive resilience w... | BeFree,GAD | 25599330 | Detail |
0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
0.022 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,GAD | Detail | |
0.106 | Diabetes Mellitus, Non-Insulin-Dependent | Type 2 diabetes is associated with increased expression of APOE, BAX, MMP1, NFKB... | BeFree,GAD,LHGDN | 23337395 | Detail |
0.106 | Diabetes Mellitus, Non-Insulin-Dependent | We assessed relative telomere length and apolipoprotein E genotype in subjects w... | BeFree,GAD,LHGDN | 25440562 | Detail |
0.003 | Diabetic Angiopathies | NA | BeFree,GAD | Detail | |
0.046 | Diabetic Nephropathy | Apo E gene polymorphism affects development of type 2 diabetic nephropathy in As... | BeFree,GAD,LHGDN | 25196797 | Detail |
0.006 | Diabetic Neuropathies | NA | BeFree,GAD | Detail | |
0.008 | diabetic retinopathy | NA | BeFree,GAD | Detail | |
0.002 | diarrhea | NA | GAD | Detail | |
0.002 | Infantile Diarrhea | NA | GAD | Detail | |
0.030 | Down syndrome | Similar efforts are occurring in an extended Colombian family with a PSEN1 mutat... | BeFree,GAD,LHGDN | 25217249 | Detail |
0.002 | Drug toxicity | NA | GAD | Detail | |
0.003 | Dyskinetic syndrome | NA | BeFree,LHGDN | Detail | |
0.002 | dystonia | NA | GAD | Detail | |
<0.001 | eclampsia | NA | BeFree | Detail | |
0.002 | Edema | NA | GAD | Detail | |
0.120 | Pathological accumulation of air in tissues | NA | CTD_human | Detail | |
0.006 | encephalitis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
<0.001 | endometrial hyperplasia | Association of the apolipoprotein E 2 allele with concurrent occurrence of endom... | BeFree | 25741405 | Detail |
<0.001 | endometriosis | NA | BeFree | Detail | |
0.004 | epilepsy | NA | BeFree,GAD | Detail | |
0.024 | Epilepsy, Temporal Lobe | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Epilepsy, Post-Traumatic | NA | GAD | Detail | |
<0.001 | Exanthema | NA | BeFree | Detail | |
0.002 | Exophthalmos | NA | GAD | Detail | |
0.003 | Fatigue | NA | BeFree,GAD | Detail | |
0.016 | Fatty Liver | Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atheroscleros... | BeFree,GAD,LHGDN | 25392542 | Detail |
0.002 | Fetal Diseases | NA | GAD | Detail | |
0.005 | Fetal Growth Retardation | NA | GAD,LHGDN | Detail | |
0.002 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
0.003 | Gall Bladder Diseases | NA | BeFree,GAD | Detail | |
0.006 | glaucoma | NA | BeFree,GAD | Detail | |
0.002 | Angle Closure Glaucoma | NA | GAD | Detail | |
0.031 | Glaucoma, Open-Angle | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | glioblastoma | NA | BeFree,GAD | Detail | |
0.003 | glomerulonephritis | NA | BeFree,GAD | Detail | |
<0.001 | IgA glomerulonephritis | NA | BeFree | Detail | |
0.080 | membranous glomerulonephritis | NA | BeFree,RGD | Detail | |
<0.001 | Nodular glomerulosclerosis | NA | BeFree | Detail | |
0.005 | Focal glomerulosclerosis | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | gout | NA | GAD | Detail | |
0.002 | Growth Disorders | NA | GAD | Detail | |
0.003 | Guillain-Barre syndrome | NA | BeFree,GAD | Detail | |
0.004 | Hallucinations | NA | BeFree,GAD | Detail | |
0.002 | Head and Neck Neoplasms | NA | GAD | Detail | |
<0.001 | Headache | NA | BeFree | Detail | |
0.003 | Sensorineural Hearing Loss (disorder) | NA | BeFree,GAD | Detail | |
0.003 | cardiac arrest | NA | BeFree,GAD | Detail | |
0.015 | congenital heart defects | NA | BeFree,GAD | Detail | |
0.014 | Heart Diseases | Trade-offs in the effects of the apolipoprotein E polymorphism on risks of disea... | BeFree,GAD,LHGDN | 25482294 | Detail |
<0.001 | Heart failure | NA | BeFree | Detail | |
<0.001 | congestive heart failure | NA | BeFree | Detail | |
<0.001 | Ventricular Septal Defects | NA | BeFree | Detail | |
<0.001 | heart valve disease | NA | BeFree | Detail | |
0.002 | hemiplegia | NA | GAD | Detail | |
0.003 | hemochromatosis | NA | BeFree,LHGDN | Detail | |
0.007 | Hemorrhage | NA | GAD,LHGDN | Detail | |
0.005 | hepatitis | NA | GAD,LHGDN | Detail | |
0.005 | hepatitis B | NA | BeFree,GAD | Detail | |
<0.001 | Hepatitis, Chronic | NA | BeFree | Detail | |
0.010 | hepatitis C | NA | BeFree,GAD,LHGDN | Detail | |
0.122 | Hepatolenticular Degeneration | NA | CTD_human,GAD | Detail | |
<0.001 | Herpes NOS | NA | BeFree | Detail | |
0.005 | genital herpes | NA | BeFree,GAD | Detail | |
0.003 | Herpes Labialis | NA | BeFree,GAD | Detail | |
0.005 | Herpes Simplex Infections | NA | BeFree,GAD | Detail | |
<0.001 | Keratitis, Herpetic | NA | BeFree | Detail | |
<0.001 | Herpes zoster disease | NA | BeFree | Detail | |
0.002 | Herpesviridae Infections | NA | GAD | Detail | |
0.024 | HIV Infections | These data replicate and strengthen prior findings of the lack of association be... | BeFree,GAD | 25388225 | Detail |
<0.001 | Hodgkin Disease | NA | BeFree | Detail | |
0.004 | Huntington disease | NA | BeFree,GAD | Detail | |
<0.001 | Hydrocephalus, Normal Pressure | NA | BeFree | Detail | |
0.202 | Hypercholesterolemia | Slovenian children born between 1989 and 2009 (n = 272) with TC >6 mmol/l (231.7... | BeFree,CTD_human,GAD,LHGDN | 26361156 | Detail |
0.138 | Hypercholesterolemia, Familial | Metaanalysis of the weighted 6-SNP score, on the basis of polymorphisms in CELSR... | BeFree,CTD_human,GAD | 25414277 | Detail |
0.138 | Hypercholesterolemia, Familial | Similar to its existing use in the diagnosis of monogenic dyslipidemias such as ... | BeFree,CTD_human,GAD | 25731628 | Detail |
<0.001 | hyperglycemia | NA | BeFree | Detail | |
0.005 | hyperinsulinism | NA | BeFree,GAD | Detail | |
0.303 | Hyperlipidemia | Primary genetic investigation of a hyperlipidemia model: molecular characteristi... | BeFree,CTD_human,GAD,LHGDN,RGD | 25006576 | Detail |
0.303 | Hyperlipidemia | Association of apolipoprotein E gene polymorphism with end-stage renal disease a... | BeFree,CTD_human,GAD,LHGDN,RGD | 25155022 | Detail |
0.391 | hyperlipoproteinemia type III | We evaluated whether and to what extent the APOE genotype modifies the relation ... | BeFree,CLINVAR,CTD_human,GAD,ORPHANET | 24946908 | Detail |
0.003 | hyperlipoproteinemia type IV | NA | BeFree,GAD | Detail | |
0.002 | Disorders of Excessive Somnolence | NA | GAD | Detail | |
0.291 | Hypertensive disease | Hypertension moderates the effect of APOE on 21-year cognitive trajectories. | BeFree,CTD_human,GAD,RGD | 24956008 | Detail |
0.291 | Hypertensive disease | In conclusion, the results of this epistasis study indicated significant associa... | BeFree,CTD_human,GAD,RGD | 25055800 | Detail |
0.291 | Hypertensive disease | These results provide tentative evidence that APOE genotype moderates the associ... | BeFree,CTD_human,GAD,RGD | 25672766 | Detail |
0.291 | Hypertensive disease | Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: ... | BeFree,CTD_human,GAD,RGD | 25688603 | Detail |
0.291 | Hypertensive disease | Predictors of MCI were APOE ε4 allele (hazard ratio [HR] 1.89; p = 0.008), curre... | BeFree,CTD_human,GAD,RGD | 25854867 | Detail |
0.003 | pulmonary hypertension | NA | LHGDN | Detail | |
0.059 | Hypertriglyceridemia | NA | GAD,LHGDN | Detail | |
0.004 | Hypobetalipoproteinemias | NA | BeFree,LHGDN | Detail | |
0.006 | hypoglycemia | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | hypopituitarism | NA | BeFree,GAD | Detail | |
0.005 | hypothyroidism | NA | BeFree,GAD | Detail | |
<0.001 | Illusions | NA | BeFree | Detail | |
0.002 | Neonatal disorder | NA | GAD | Detail | |
0.019 | Inflammation | NA | GAD | Detail | |
0.003 | Inflammatory Bowel Diseases | Genetic association of apolipoprotein E polymorphisms with inflammatory bowel di... | BeFree,GAD | 25624723 | Detail |
0.009 | Insulin resistance | NA | GAD | Detail | |
0.015 | ischemia | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | Creutzfeldt-Jakob disease | NA | BeFree,GAD | Detail | |
0.003 | Ketosis | NA | BeFree,GAD | Detail | |
0.011 | Kidney Diseases | Our meta-analysis supports that the ApoE ε2 allele and ACACB rs2268388 C>T might... | BeFree,GAD | 25262148 | Detail |
0.003 | Kidney Failure, Acute | NA | BeFree,GAD | Detail | |
0.018 | Kidney Failure, Chronic | Association of apolipoprotein E gene polymorphism with end-stage renal disease a... | BeFree,GAD | 25155022 | Detail |
0.002 | Kidney Neoplasm | NA | GAD | Detail | |
0.005 | Premature Obstetric Labor | NA | GAD | Detail | |
0.002 | Lead Poisoning | NA | GAD | Detail | |
0.005 | Learning Disorders | NA | GAD | Detail | |
<0.001 | Lecithin Acyltransferase Deficiency | NA | BeFree | Detail | |
<0.001 | Left-Sided Heart Failure | NA | BeFree | Detail | |
0.003 | leukemia | NA | BeFree,LHGDN | Detail | |
0.003 | chronic lymphocytic leukemia | NA | BeFree,GAD | Detail | |
<0.001 | lipodystrophy | NA | BeFree | Detail | |
<0.001 | Hyperlipoproteinemia Type I | NA | BeFree | Detail | |
0.013 | liver cirrhosis | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | Liver Cirrhosis, Alcoholic | NA | BeFree,GAD | Detail | |
0.002 | Biliary cirrhosis | NA | GAD | Detail | |
0.001 | Liver diseases | NA | BeFree | Detail | |
0.001 | Liver neoplasms | NA | BeFree | Detail | |
0.007 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
0.123 | Lung Neoplasms | NA | CTD_human,LHGDN | Detail | |
0.011 | Lupus Erythematosus, Systemic | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | lymphoma | NA | BeFree,GAD | Detail | |
0.002 | Lymphoma, Non-Hodgkin | NA | GAD | Detail | |
0.001 | Machado-Joseph disease | The role of apolipoprotein E as a risk factor for an earlier age at onset for Ma... | BeFree | 25369462 | Detail |
<0.001 | macular degeneration | NA | BeFree | Detail | |
0.006 | malaria | NA | BeFree,LHGDN | Detail | |
0.002 | Malaria, Falciparum | NA | GAD | Detail | |
<0.001 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
0.002 | Animal Mammary Neoplasms | NA | GAD | Detail | |
<0.001 | melanoma | NA | BeFree | Detail | |
0.081 | Memory Disorders | NA | BeFree,GAD | Detail | |
0.002 | Mental Retardation | NA | BeFree | Detail | |
0.120 | Mercury Poisoning | NA | CTD_human | Detail | |
0.003 | Metabolic Diseases | NA | BeFree,GAD | Detail | |
0.003 | mitral valve stenosis | NA | BeFree,GAD | Detail | |
0.002 | Mouth, Edentulous | NA | GAD | Detail | |
0.233 | multiple sclerosis | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | spinal muscular atrophy | NA | BeFree | Detail | |
0.003 | myopathy | NA | BeFree,GAD | Detail | |
0.003 | myasthenia gravis | NA | BeFree,GAD | Detail | |
<0.001 | Mydriasis | NA | BeFree | Detail | |
0.340 | myocardial infarction | Meta-analysis of apolipoprotein E gene polymorphism and susceptibility of myocar... | BeFree,CLINVAR,CTD_human,GAD,LHGDN | 25111308 | Detail |
<0.001 | Myoclonus | NA | BeFree | Detail | |
<0.001 | myopia | NA | BeFree | Detail | |
<0.001 | myositis | NA | BeFree | Detail | |
<0.001 | Myotonic dystrophy | NA | BeFree | Detail | |
0.002 | nasopharyngitis | NA | GAD | Detail | |
<0.001 | Neoplasm Metastasis | Secretomes are a potential source of molecular targets for cancer therapies and ... | BeFree | 25098600 | Detail |
0.022 | nephrotic syndrome | NA | BeFree,GAD,LHGDN | Detail | |
0.127 | Nerve Degeneration | NA | CTD_human,GAD | Detail | |
0.009 | nervous system disorder | NA | BeFree,GAD | Detail | |
<0.001 | neuroblastoma | NA | BeFree | Detail | |
<0.001 | Neuromuscular Diseases | NA | BeFree | Detail | |
<0.001 | Niemann-Pick Diseases | NA | BeFree | Detail | |
0.002 | Obesity, Morbid | NA | GAD | Detail | |
<0.001 | Disorder of the optic nerve | NA | BeFree | Detail | |
<0.001 | optic neuritis | NA | BeFree | Detail | |
<0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
0.010 | osteoporosis | NA | BeFree,GAD | Detail | |
0.007 | Osteoporosis, Postmenopausal | NA | GAD | Detail | |
<0.001 | ovarian carcinoma | NA | BeFree | Detail | |
0.080 | Pancreatic Neoplasm | NA | RGD | Detail | |
0.007 | pancreatitis | NA | GAD | Detail | |
<0.001 | papilloma | NA | BeFree | Detail | |
0.080 | Parkinson disease | Among PD patients without dementia, the APOE ε4 allele was only associated with ... | BeFree,GAD,LHGDN | 25178429 | Detail |
0.002 | Perceptual Disorders | NA | GAD | Detail | |
0.002 | Periodontal Diseases | NA | GAD | Detail | |
0.003 | Peripheral neuropathy | NA | BeFree,GAD | Detail | |
<0.001 | Pituitary Diseases | NA | BeFree | Detail | |
0.006 | polycystic ovary syndrome | NA | BeFree,GAD | Detail | |
<0.001 | Postherpetic neuralgia | NA | BeFree | Detail | |
0.021 | Postoperative Complications | NA | GAD | Detail | |
0.012 | pre-eclampsia | NA | GAD | Detail | |
0.005 | Pregnancy Complications | NA | GAD | Detail | |
0.002 | Pregnancy Complications, Cardiovascular | NA | GAD | Detail | |
0.002 | Prenatal Exposure Delayed Effects | NA | GAD | Detail | |
0.003 | Prostatic Neoplasms | NA | BeFree,LHGDN | Detail | |
0.120 | proteinuria | NA | CTD_human | Detail | |
<0.001 | pseudoxanthoma elasticum | Increased cholesterol biosynthesis, elevated PCSK9 levels and reduced APOE mRNA ... | BeFree | 25064003 | Detail |
0.129 | psoriasis | NA | BeFree,CTD_human,GAD | Detail | |
0.005 | Tension Headache | NA | BeFree,GAD | Detail | |
0.007 | Psychomotor Disorders | NA | GAD | Detail | |
0.003 | Psychotic Disorders | NA | BeFree | Detail | |
0.003 | pulmonary embolism | NA | BeFree,GAD | Detail | |
<0.001 | quadriplegia | NA | BeFree | Detail | |
0.002 | Rectal Neoplasms | NA | GAD | Detail | |
0.009 | kidney failure | NA | BeFree,GAD | Detail | |
<0.001 | retinal degeneration | NA | BeFree | Detail | |
<0.001 | Retinal Diseases | NA | BeFree | Detail | |
0.003 | Rett syndrome | NA | BeFree,GAD | Detail | |
0.002 | Kaposi sarcoma | NA | GAD | Detail | |
0.250 | schizophrenia | In each case, a single gene is represented in a plurality of epistatic interacti... | BeFree,CTD_human,GAD,LHGDN,RGD | 25403528 | Detail |
<0.001 | Schizophreniform Disorders | NA | BeFree | Detail | |
<0.001 | systemic scleroderma | NA | BeFree | Detail | |
0.005 | Sclerosis | NA | GAD | Detail | |
0.127 | Seizures | NA | BeFree,CTD_human,GAD | Detail | |
<0.001 | Age-related cataract | The KLC1 and APOE genes may be novel susceptibility genes for age-related catara... | BeFree | 25883527 | Detail |
0.005 | Sensation Disorders | NA | GAD | Detail | |
<0.001 | Shared Paranoid Disorder | NA | BeFree | Detail | |
0.002 | Shock, Cardiogenic | NA | GAD | Detail | |
<0.001 | Shy-Drager Syndrome | NA | BeFree | Detail | |
<0.001 | Sickle Cell Trait | NA | BeFree | Detail | |
<0.001 | siderosis | NA | BeFree | Detail | |
0.007 | Sleep Apnea Syndromes | NA | BeFree,GAD | Detail | |
<0.001 | Sleep disturbances | NA | BeFree | Detail | |
0.005 | Spina Bifida Cystica | NA | GAD,LHGDN | Detail | |
0.005 | Compression of spinal cord | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Spinal Cord Diseases | NA | BeFree,GAD | Detail | |
0.002 | Spinal Osteophytosis | NA | GAD | Detail | |
0.120 | Splenomegaly | NA | CTD_human | Detail | |
0.002 | spondylosis | NA | GAD | Detail | |
0.003 | Stomach Neoplasms | NA | LHGDN | Detail | |
0.003 | Stomatitis, Herpetic | NA | BeFree,GAD | Detail | |
0.004 | post-traumatic stress disorder | The Number of Cysteine Residues per Mole in Apolipoprotein E Is Associated With ... | BeFree,LHGDN | 25751510 | Detail |
0.001 | Stress, Psychological | NA | BeFree | Detail | |
0.115 | Cerebrovascular accident | The data about apolipoprotein E gene (APOE) genotype and the risk of stroke are ... | BeFree,GAD,LHGDN | 24846706 | Detail |
0.115 | Cerebrovascular accident | Association of the ApoE gene polymorphism and dietary factors with cerebral infa... | BeFree,GAD,LHGDN | 25730003 | Detail |
0.055 | Subarachnoid Hemorrhage | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Substance Withdrawal Syndrome | NA | GAD | Detail | |
0.005 | sudden infant death syndrome | NA | BeFree,GAD,LHGDN | Detail | |
0.006 | progressive supranuclear palsy | NA | BeFree,GAD | Detail | |
<0.001 | Tangier disease | NA | BeFree | Detail | |
0.006 | tetralogy of Fallot | NA | BeFree,GAD,LHGDN | Detail | |
0.007 | thrombosis | NA | GAD | Detail | |
<0.001 | tic disorder | NA | BeFree | Detail | |
0.002 | Tinea Versicolor | NA | GAD | Detail | |
<0.001 | Tremor | Analyses also considered APOE genotype and tremor- vs. rigidity-dominant phenoty... | BeFree | 25596881 | Detail |
0.003 | Trisomy | NA | BeFree,GAD | Detail | |
0.002 | Unconscious State | NA | GAD | Detail | |
0.002 | Unipolar Depression | NA | BeFree | Detail | |
<0.001 | Unspecified idiopathic peripheral neuropathy | NA | BeFree | Detail | |
0.002 | uremia | NA | GAD | Detail | |
0.024 | Vascular Diseases | Influence of APOE-2 genotype on the relation between adiposity and plasma lipid ... | BeFree,GAD | 24946908 | Detail |
0.024 | Vascular Diseases | APOE genotype was significantly associated with performance on several different... | BeFree,GAD | 25247594 | Detail |
0.024 | Vascular Diseases | Predictors of MCI were APOE ε4 allele (hazard ratio [HR] 1.89; p = 0.008), curre... | BeFree,GAD | 25854867 | Detail |
0.002 | Venous Thrombosis | NA | GAD | Detail | |
0.002 | Virilism | NA | GAD | Detail | |
0.001 | Virus Diseases | Apolipoprotein E and protection against hepatitis E viral infection in American ... | BeFree | 26096528 | Detail |
0.002 | Low Vision | NA | GAD | Detail | |
0.002 | Vitamin B 12 Deficiency | NA | GAD | Detail | |
0.002 | Vitamin K Deficiency | NA | GAD | Detail | |
0.002 | Weight Gain | NA | GAD | Detail | |
0.003 | xanthomatosis | NA | BeFree,GAD | Detail | |
<0.001 | Cerebral Thrombosis | NA | BeFree | Detail | |
0.002 | holoprosencephaly | NA | GAD | Detail | |
<0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
<0.001 | Pleural Effusion, Malignant | NA | BeFree | Detail | |
0.005 | Tooth Loss | NA | GAD | Detail | |
0.004 | motor neuron disease | NA | BeFree,LHGDN | Detail | |
0.002 | Lymphoma, AIDS-Related | NA | GAD | Detail | |
0.003 | Peripheral Vascular Diseases | NA | BeFree,GAD | Detail | |
0.167 | cerebral amyloid angiopathy | To gain insight into different cerebral amyloid angiopathy (CAA) phenotypes and ... | BeFree,CTD_human,GAD,LHGDN | 25716356 | Detail |
0.167 | cerebral amyloid angiopathy | APOE ε4 is associated with recurrent ICH in nonlobar brain regions, providing fu... | BeFree,CTD_human,GAD,LHGDN | 26115730 | Detail |
0.002 | Yin Deficiency | NA | GAD | Detail | |
<0.001 | Alagille syndrome | NA | BeFree | Detail | |
<0.001 | hepatitis E | Apolipoprotein E and protection against hepatitis E viral infection in American ... | BeFree | 26096528 | Detail |
0.015 | Neurofibrillary degeneration (morphologic abnormality) | APOE [Latin Small Letter Open E]4 is a major risk factor for late-onset Alzheime... | BeFree | 23715207 | Detail |
0.005 | Polycystic Kidney, Autosomal Dominant | NA | GAD,LHGDN | Detail | |
0.002 | Epilepsy, Complex Partial | NA | GAD | Detail | |
<0.001 | autosomal recessive polycystic kidney disease | NA | BeFree | Detail | |
0.002 | essential hypertension | NA | BeFree | Detail | |
<0.001 | Encephalopathies | NA | BeFree | Detail | |
0.006 | Agitation | NA | BeFree,GAD | Detail | |
0.001 | Apathy | Reduced brain-derived neurotrophic factor (BDNF) signaling is considered as a pa... | BeFree | 25024337 | Detail |
0.001 | Apathy | There was a synergistic interaction between depression or apathy and APOE ε4 in ... | BeFree | 25653291 | Detail |
<0.001 | Synovial Cyst | NA | BeFree | Detail | |
0.003 | Alcohol abuse | NA | BeFree,GAD | Detail | |
<0.001 | soft neurological signs | NA | BeFree | Detail | |
0.011 | Depressive Symptoms | Predictors of MCI were APOE ε4 allele (hazard ratio [HR] 1.89; p = 0.008), curre... | BeFree,GAD | 25854867 | Detail |
<0.001 | Depressive Syndrome | NA | BeFree | Detail | |
<0.001 | Intravenous Drug Abuse | NA | BeFree | Detail | |
0.003 | cataract | NA | BeFree,GAD | Detail | |
<0.001 | Pancreatitis, Chronic | NA | BeFree | Detail | |
<0.001 | Cervical myelopathy | NA | BeFree | Detail | |
0.002 | Left Ventricular Hypertrophy | NA | GAD | Detail | |
<0.001 | Deep Vein Thrombosis | NA | BeFree | Detail | |
0.006 | Migraine Disorders | NA | BeFree,GAD | Detail | |
0.080 | sciatic neuropathy | NA | RGD | Detail | |
<0.001 | Complex partial seizures | NA | BeFree | Detail | |
<0.001 | Genital ulceration | NA | BeFree | Detail | |
<0.001 | Sensory neuropathy | NA | BeFree | Detail | |
<0.001 | Atrophic condition of skin | APOE ɛ4 was associated with atrophic hippocampal volume in MRI markers, increase... | BeFree | 24838911 | Detail |
0.002 | Premature Birth | NA | GAD | Detail | |
0.009 | Intracranial Hemorrhages | NA | GAD | Detail | |
0.002 | intracranial hypertension | NA | GAD | Detail | |
0.049 | Myocardial Ischemia | Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ ... | BeFree,GAD,LHGDN | 25377726 | Detail |
<0.001 | Arterial thrombosis | Synthetic gestagens exert differential effects on arterial thrombosis and aortic... | BeFree | 24923668 | Detail |
<0.001 | Adenocarcinoma of lung (disorder) | Secretomes are a potential source of molecular targets for cancer therapies and ... | BeFree | 25098600 | Detail |
<0.001 | Patau syndrome | NA | BeFree | Detail | |
<0.001 | hypoplastic left heart syndrome | NA | BeFree | Detail | |
<0.001 | lingual-facial-buccal dyskinesia | NA | BeFree | Detail | |
<0.001 | low tension glaucoma | NA | BeFree | Detail | |
<0.001 | Common ventricle | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of gallbladder | NA | BeFree | Detail | |
0.008 | Lipid Metabolism Disorders | NA | BeFree,GAD | Detail | |
<0.001 | migraine with aura | NA | BeFree | Detail | |
<0.001 | Eyelid Xanthoma | NA | BeFree | Detail | |
<0.001 | Hearing Loss, Mixed Conductive-Sensorineural | NA | BeFree | Detail | |
0.001 | acute myocardial infarction | NA | BeFree | Detail | |
<0.001 | Old myocardial infarction | NA | BeFree | Detail | |
0.002 | Atherosclerosis of aorta | No renal phenotype in human phospholipid transfer protein transgenic apolipoprot... | BeFree | 25651711 | Detail |
<0.001 | Disease of capillaries | NA | BeFree | Detail | |
0.002 | iron deficiency anemia | NA | GAD | Detail | |
0.003 | Malnutrition | NA | BeFree,LHGDN | Detail | |
0.002 | AIDS-Related Opportunistic Infections | NA | GAD | Detail | |
0.004 | Prion Diseases | Seven patients had high levels of PrP, low Aβ42, high APOE-4, and 40% nerve cell... | BeFree,GAD | 26226132 | Detail |
0.002 | Akathisia, Drug-Induced | NA | GAD | Detail | |
0.005 | Aneurysm, Ruptured | NA | GAD | Detail | |
0.002 | Aortic Aneurysm, Abdominal | NA | BeFree | Detail | |
0.003 | Smith-Lemli-Opitz syndrome | NA | BeFree,GAD | Detail | |
0.002 | Amyloid Neuropathies, Familial | NA | GAD | Detail | |
0.006 | exfoliation syndrome | NA | BeFree,GAD | Detail | |
0.002 | Paramyxoviridae Infections | NA | GAD | Detail | |
<0.001 | hepatoblastoma | NA | BeFree | Detail | |
<0.001 | teratocarcinoma | NA | BeFree | Detail | |
<0.001 | Niemann-Pick disease, type C | NA | BeFree | Detail | |
<0.001 | Systolic hypertension | NA | BeFree | Detail | |
0.001 | Lesion of brain | NA | BeFree | Detail | |
<0.001 | Premature aging syndrome | NA | BeFree | Detail | |
<0.001 | Psychological symptom | NA | BeFree | Detail | |
<0.001 | Psychiatric symptom | NA | BeFree | Detail | |
<0.001 | Dysphoric mood | NA | BeFree | Detail | |
<0.001 | Bradykinesia | NA | BeFree | Detail | |
<0.001 | Hallucinations, Visual | NA | BeFree | Detail | |
0.014 | Memory impairment | The apolipoprotein E ε4 (ApoE ε4) allele not only represents the strongest singl... | BeFree,GAD | 24989884 | Detail |
0.014 | Memory impairment | Compared with the stable memory trajectory, high Αβ (relative risk ratio [RRR] =... | BeFree,GAD | 25585532 | Detail |
0.014 | Memory impairment | In conclusion, behavioural Alzheimer's disease presentations are characterized b... | BeFree,GAD | 26141491 | Detail |
<0.001 | Amnesia, Anterograde | We measured RA, anterograde amnesia (AA), brain measures, apolipoprotein-E statu... | BeFree | 25068664 | Detail |
0.002 | Personality Traits | NA | GAD | Detail | |
<0.001 | Extrapyramidal sign | NA | BeFree | Detail | |
<0.001 | Sensory denervation disorder | NA | BeFree | Detail | |
0.122 | Mental deterioration | NA | GAD,GWASCAT | Detail | |
0.009 | Cerebral atrophy | It was therefore investigated whether the association between load of WMHs and b... | BeFree | 24313901 | Detail |
0.009 | Cerebral atrophy | This study evaluates the individual, as well as relative and joint value of indi... | BeFree | 24371799 | Detail |
0.009 | Cerebral atrophy | Genetic interaction of PICALM and APOE is associated with brain atrophy and cogn... | BeFree | 24613704 | Detail |
0.008 | Pick Disease of the Brain | Only 1 FTD patient (homozygous for apolipoprotein E ε4) displayed high cortical ... | BeFree,GAD | 25655625 | Detail |
<0.001 | Dementia associated with alcoholism | NA | BeFree | Detail | |
<0.001 | Alcohol withdrawal syndrome | NA | BeFree | Detail | |
0.002 | Age-related cognitive decline | Perhaps less well known, and certainly less well characterized, is that this ϵ4 ... | BeFree | 25711453 | Detail |
<0.001 | Alcohol or Other Drugs use | NA | BeFree | Detail | |
0.006 | Inclusion Body Myositis (disorder) | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Prodrome | A lower EF performance in cognitively intact older APOE ε4 allele carriers might... | BeFree | 25365563 | Detail |
0.008 | coronary stenosis | APOE gene polymorphism and risk of coronary stenosis in Pakistani population. | BeFree,GAD | 25883965 | Detail |
0.003 | Malignant neoplasm of lung | NA | BeFree,GAD | Detail | |
<0.001 | Parkinsonian Disorders | NA | BeFree | Detail | |
<0.001 | Drug usage | NA | BeFree | Detail | |
0.017 | Disease Progression | NA | GAD | Detail | |
0.002 | Persistent Vegetative State | NA | GAD | Detail | |
0.005 | Ventricular Dysfunction, Left | NA | GAD | Detail | |
<0.001 | Parasitemia | NA | BeFree | Detail | |
0.002 | Sepsis | NA | GAD | Detail | |
<0.001 | Carcinoma of ampulla of Vater | NA | BeFree | Detail | |
<0.001 | Apraxia of Phonation | APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speec... | BeFree | 24985533 | Detail |
<0.001 | Dilatation of aorta | Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and r... | BeFree | 25301844 | Detail |
<0.001 | Cerebral Vasospasm | NA | BeFree | Detail | |
<0.001 | Chronic Periodontitis | Apolipoprotein E gene polymorphisms in relation to chronic periodontitis, period... | BeFree | 25545672 | Detail |
<0.001 | Oropharyngeal Dysphagia | We report the association between ApoE 4 homozygous genotype and self-reported o... | BeFree | 24261350 | Detail |
<0.001 | Progressive intrahepatic cholestasis (disorder) | NA | BeFree | Detail | |
<0.001 | Amyloid nephropathy | NA | BeFree | Detail | |
<0.001 | Localized amyloidosis | NA | BeFree | Detail | |
<0.001 | Familial Cerebral Amyloid Angiopathy | NA | BeFree | Detail | |
<0.001 | Hereditary Cerebral Amyloid Angiopathy, Dutch Type | NA | BeFree | Detail | |
<0.001 | Amyloidosis, Primary Cutaneous | NA | BeFree | Detail | |
<0.001 | Renal glomerular disease | NA | BeFree | Detail | |
<0.001 | Acute nephropathy | NA | BeFree | Detail | |
<0.001 | Leukoencephalopathies | NA | BeFree | Detail | |
<0.001 | Triplegia | NA | BeFree | Detail | |
0.003 | macular retinal edema | NA | BeFree,LHGDN | Detail | |
0.001 | Exudative age-related macular degeneration | Polymorphisms in the APOE gene and the location of retinal fluid in eyes with ne... | BeFree | 25077528 | Detail |
<0.001 | Cortical cataract | To study whether presenilin 1 (PSEN1), apolipoprotein E (APOE), and kinesin ligh... | BeFree | 25883527 | Detail |
<0.001 | Impaired glucose tolerance | NA | BeFree | Detail | |
0.005 | Herpes encephalitis | NA | BeFree,GAD | Detail | |
0.003 | Familial Alzheimer Disease (FAD) | NA | BeFree | Detail | |
<0.001 | Behavioral tic | NA | BeFree | Detail | |
<0.001 | Iron Overload | NA | BeFree | Detail | |
<0.001 | Sexual abuse | NA | BeFree | Detail | |
0.009 | Primary Progressive Aphasia (disorder) | APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speec... | BeFree,GAD | 24985533 | Detail |
<0.001 | Tuberous xanthoma | NA | BeFree | Detail | |
<0.001 | Xanthoma | NA | BeFree | Detail | |
<0.001 | Poisoning syndrome | NA | BeFree | Detail | |
0.003 | Obesity, Abdominal | NA | BeFree,GAD | Detail | |
0.004 | Restenosis | NA | BeFree,GAD | Detail | |
0.025 | Senile Plaques | APOE [Latin Small Letter Open E]4 is a major risk factor for late-onset Alzheime... | BeFree,GAD | 23715207 | Detail |
<0.001 | Segmental glomerulosclerosis | NA | BeFree | Detail | |
<0.001 | Infarction, Lacunar | NA | BeFree | Detail | |
0.055 | Atrophic | NA | GAD,LHGDN | Detail | |
<0.001 | Arteriovenous hemangioma | NA | BeFree | Detail | |
0.007 | frontotemporal dementia | Only 1 FTD patient (homozygous for apolipoprotein E ε4) displayed high cortical ... | BeFree,GAD | 25655625 | Detail |
<0.001 | carotid artery dissection | NA | BeFree | Detail | |
0.002 | Vertebral Artery Dissection | NA | GAD | Detail | |
0.200 | Impaired cognition | In linear mixed models, controlling for age, gender, education, and apolipoprote... | BeFree,GAD,GWASCAT | 23954042 | Detail |
0.200 | Impaired cognition | Apolipoprotein E (ApoE) is the most well-described genetic risk factor for Alzhe... | BeFree,GAD,GWASCAT | 24261350 | Detail |
0.200 | Impaired cognition | Genetic interaction of PICALM and APOE is associated with brain atrophy and cogn... | BeFree,GAD,GWASCAT | 24613704 | Detail |
0.200 | Impaired cognition | The alternative prodrome hypothesis predicts that the APOE-ε4 allele would be as... | BeFree,GAD,GWASCAT | 24853824 | Detail |
0.200 | Impaired cognition | The combined effects of metabolic syndrome and the apolipoprotein E and CYP46 ge... | BeFree,GAD,GWASCAT | 24924840 | Detail |
0.200 | Impaired cognition | Age, APOE ε4, and decline in intellectually and socially stimulating recreationa... | BeFree,GAD,GWASCAT | 24933483 | Detail |
0.200 | Impaired cognition | Hypertension moderated the effects of APOE ε4 on the rate of change for cognitiv... | BeFree,GAD,GWASCAT | 24956008 | Detail |
0.200 | Impaired cognition | Deploying a between-sibling design that allows quasi-experimental variation in g... | BeFree,GAD,GWASCAT | 25074513 | Detail |
0.200 | Impaired cognition | Moreover, the interaction of APOE by age on brain morphology may accelerate the ... | BeFree,GAD,GWASCAT | 25114090 | Detail |
0.200 | Impaired cognition | Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it co... | BeFree,GAD,GWASCAT | 25333200 | Detail |
0.200 | Impaired cognition | APOE genotype, along with other biomarkers, may be used in the future to assist ... | BeFree,GAD,GWASCAT | 25355028 | Detail |
0.200 | Impaired cognition | Influence of socio-demographic features and apolipoprotein E epsilon 4 expressio... | BeFree,GAD,GWASCAT | 25466513 | Detail |
0.200 | Impaired cognition | Higher UACR values were significantly associated with cognitive dysfunction in t... | BeFree,GAD,GWASCAT | 25530658 | Detail |
0.200 | Impaired cognition | Apolipoprotein E (ApoE) ε4 allele is a known genetic risk factor for AD, which n... | BeFree,GAD,GWASCAT | 25551132 | Detail |
0.200 | Impaired cognition | APOE allele might play a role in the occurrence of cognitive impairment after mT... | BeFree,GAD,GWASCAT | 25586534 | Detail |
0.200 | Impaired cognition | Although APOE ε4 carriers are at high risk for cognitive decline, our findings s... | BeFree,GAD,GWASCAT | 25599330 | Detail |
0.200 | Impaired cognition | Interactive effect of APOE genotype and blood pressure on cognitive decline: the... | BeFree,GAD,GWASCAT | 25672766 | Detail |
0.200 | Impaired cognition | Effects of vascular risk factors and APOE ε4 on white matter integrity and cogni... | BeFree,GAD,GWASCAT | 25672924 | Detail |
0.200 | Impaired cognition | The ε4 allele of apolipoprotein E (APOE ε4) is a well-established risk factor fo... | BeFree,GAD,GWASCAT | 25738563 | Detail |
0.200 | Impaired cognition | Among persons without dementia, the prevalence of cerebral amyloid pathology as ... | BeFree,GAD,GWASCAT | 25988462 | Detail |
0.002 | Age-associated memory impairment | NA | BeFree | Detail | |
0.004 | Glaucoma, Primary Open Angle | Analysis of the expression and polymorphism of APOE, HSP, BDNF, and GRIN2B genes... | BeFree | 25893192 | Detail |
<0.001 | Stable angina | NA | BeFree | Detail | |
<0.001 | Silent myocardial ischemia | NA | BeFree | Detail | |
<0.001 | Aortic aneurysm without mention of rupture NOS | NA | BeFree | Detail | |
<0.001 | Dissection of aorta | NA | BeFree | Detail | |
<0.001 | Chronic liver disease | NA | BeFree | Detail | |
<0.001 | Iodine deficiency syndrome | NA | BeFree | Detail | |
<0.001 | Endemic Cretinism | NA | BeFree | Detail | |
0.009 | Complications of Diabetes Mellitus | NA | GAD | Detail | |
<0.001 | Polygenic hypercholesterolemia | NA | BeFree | Detail | |
<0.001 | Cholesteryl Ester Transfer Protein Deficiency | NA | BeFree | Detail | |
<0.001 | Tetralogy of Fallot with pulmonary atresia | NA | BeFree | Detail | |
<0.001 | dementia in parkinson's disease | NA | BeFree | Detail | |
0.002 | Nonorganic psychosis | NA | BeFree | Detail | |
<0.001 | Wernicke-Korsakoff syndrome | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of prostate | NA | BeFree,GAD | Detail | |
0.002 | Pancreatitis, Alcoholic | NA | GAD | Detail | |
<0.001 | Hereditary hemochromatosis | NA | BeFree | Detail | |
<0.001 | Subcortical Vascular Dementia | NA | BeFree | Detail | |
<0.001 | Corticobasal degeneration | NA | BeFree | Detail | |
<0.001 | multiple system atrophy | NA | BeFree | Detail | |
<0.001 | thrombophilia | NA | BeFree | Detail | |
0.081 | Non-alcoholic Fatty Liver Disease | NA | BeFree,RGD | Detail | |
0.005 | Chronic Kidney Insufficiency | NA | BeFree,GAD | Detail | |
<0.001 | Congenital Myotonic Dystrophy | NA | BeFree | Detail | |
<0.001 | Anxiety and fear | NA | BeFree | Detail | |
<0.001 | Mobility poor | NA | BeFree | Detail | |
<0.001 | neuropathy | NA | BeFree | Detail | |
<0.001 | Spastic | NA | BeFree | Detail | |
0.002 | Traumatic cerebral hemorrhage | NA | GAD | Detail | |
<0.001 | endometrial carcinoma | Association of the apolipoprotein E 2 allele with concurrent occurrence of endom... | BeFree | 25741405 | Detail |
0.228 | dementia | Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late li... | BeFree,GAD,LHGDN | 23883793 | Detail |
0.228 | dementia | High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorder... | BeFree,GAD,LHGDN | 23978325 | Detail |
0.228 | dementia | The presence of apraxia in AD is related to dementia severity and APOE ε4. | BeFree,GAD,LHGDN | 24603451 | Detail |
0.228 | dementia | To explore apolipoprotein E gene variants distribution among the patients of Alz... | BeFree,GAD,LHGDN | 24678786 | Detail |
0.228 | dementia | Results indicate that the relationship between sedentary time and CBF in the lef... | BeFree,GAD,LHGDN | 24685629 | Detail |
0.228 | dementia | The MCI subjects who developed dementia were more likely to carry at least one c... | BeFree,GAD,LHGDN | 24685632 | Detail |
0.228 | dementia | Association of apolipoprotein E-e4 and dementia declines with age. | BeFree,GAD,LHGDN | 24731780 | Detail |
0.228 | dementia | The cluster-derived normal group had significantly fewer APOE ε4 carriers and fe... | BeFree,GAD,LHGDN | 24857234 | Detail |
0.228 | dementia | Apolipoprotein E ε4 (APOE ε4) is a risk factor for β-amyloid deposition in Alzhe... | BeFree,GAD,LHGDN | 24985533 | Detail |
0.228 | dementia | The levels of miR‑193b, exosomal miR‑193b, Aβ, tau, p‑tau, HCY and APOE in sampl... | BeFree,GAD,LHGDN | 25119742 | Detail |
0.228 | dementia | Cognitively healthy NDFAM showed a higher net cognitive gain after CS, as reflec... | BeFree,GAD,LHGDN | 25187003 | Detail |
0.228 | dementia | Increased WMH volume was associated with increased frequency of dementia irrespe... | BeFree,GAD,LHGDN | 25304991 | Detail |
0.228 | dementia | We assessed relative telomere length and apolipoprotein E genotype in subjects w... | BeFree,GAD,LHGDN | 25440562 | Detail |
0.228 | dementia | Influence of socio-demographic features and apolipoprotein E epsilon 4 expressio... | BeFree,GAD,LHGDN | 25466513 | Detail |
0.228 | dementia | We included 209 consecutive late-onset AD patients to find out which factors amo... | BeFree,GAD,LHGDN | 25591674 | Detail |
0.228 | dementia | Apolipoprotein E (APOE) ε4 is an established risk factor for cognitive decline a... | BeFree,GAD,LHGDN | 25599330 | Detail |
0.228 | dementia | Mediation analysis was used to estimate the direct and indirect effects of APOE ... | BeFree,GAD,LHGDN | 25623662 | Detail |
0.228 | dementia | There was a synergistic interaction between depression or apathy and APOE ε4 in ... | BeFree,GAD,LHGDN | 25653291 | Detail |
0.228 | dementia | This article considers APOE ϵ4 effects on cognition in people without dementia, ... | BeFree,GAD,LHGDN | 25711453 | Detail |
0.228 | dementia | The allele frequency of APOE ε4 varies both across and within populations, and t... | BeFree,GAD,LHGDN | 25738563 | Detail |
0.228 | dementia | Subgroup analyses indicated that (1) the significantly increased risk of AD from... | BeFree,GAD,LHGDN | 25763939 | Detail |
0.228 | dementia | We have also established novel methods to express apoE isoforms in mouse brain t... | BeFree,GAD,LHGDN | 25871773 | Detail |
0.228 | dementia | Among persons without dementia, the prevalence of cerebral amyloid pathology as ... | BeFree,GAD,LHGDN | 25988462 | Detail |
0.228 | dementia | These findings indicate the potential clinical utility of amyloid imaging for di... | BeFree,GAD,LHGDN | 25988463 | Detail |
0.228 | dementia | Eleven patients with dementia had apolipoprotein E 4 (ApoE4) and R47H genotypes. | BeFree,GAD,LHGDN | 26076170 | Detail |
0.228 | dementia | Interaction of Apolipoprotein E Genotypes, Lifestyle Factors and Future Risk of ... | BeFree,GAD,LHGDN | 26088392 | Detail |
0.002 | Overweight | NA | BeFree | Detail | |
0.002 | body mass | NA | GAD | Detail | |
<0.001 | Cerebrovascular amyloidosis | NA | BeFree | Detail | |
0.018 | Sleep Apnea, Obstructive | The relationship between obstructive sleep apnea syndrome and apolipoprotein E g... | BeFree,GAD,LHGDN | 25613112 | Detail |
0.002 | Paralysed | NA | GAD | Detail | |
0.045 | Neurodegenerative Disorders | APOE [Latin Small Letter Open E]4 is a major risk factor for late-onset Alzheime... | BeFree,GAD,LHGDN | 23715207 | Detail |
0.045 | Neurodegenerative Disorders | We included 210 consecutive patients with late-onset AD to investigate whether e... | BeFree,GAD,LHGDN | 24596166 | Detail |
0.045 | Neurodegenerative Disorders | In this regard, the GHRH-GH-IGF-1/Insulin, TOR-S6K1,NAD(+)-Sirtuin, P53, Klotho ... | BeFree,GAD,LHGDN | 25038521 | Detail |
0.045 | Neurodegenerative Disorders | Here we focused on long-living participants of the Long Life Family Study (LLFS)... | BeFree,GAD,LHGDN | 25482294 | Detail |
0.011 | Hepatitis C, Chronic | PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype ... | BeFree,GAD | 25463543 | Detail |
<0.001 | Neurobehavioral Manifestations | NA | BeFree | Detail | |
0.003 | Mood Disorders | NA | BeFree,GAD | Detail | |
<0.001 | Hypersensitive syndrome | NA | BeFree | Detail | |
<0.001 | Amyotrophic Lateral Sclerosis, Guam Form | NA | BeFree | Detail | |
0.002 | Mercury Poisoning, Nervous System | NA | GAD | Detail | |
<0.001 | Post-Concussion Syndrome | NA | BeFree | Detail | |
0.009 | Olfaction Disorders | NA | GAD | Detail | |
0.002 | Menopause present (finding) | NA | GAD | Detail | |
0.009 | Carotid Atherosclerosis | NA | BeFree,GAD | Detail | |
<0.001 | Chronic anxiety | NA | BeFree | Detail | |
<0.001 | Factor V Leiden mutation | NA | BeFree | Detail | |
0.005 | Alcohol Withdrawal Seizures | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Severe depression | NA | BeFree | Detail | |
<0.001 | cortex bone disorders | Mean expression of APOE and TOMM40 mRNA levels were higher in VL homozygotes com... | BeFree | 24439168 | Detail |
0.002 | Intraocular pressure disorder | NA | BeFree | Detail | |
<0.001 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | Cardiovascular Infections | NA | BeFree | Detail | |
0.049 | Mental Depression | The aim of this study was to investigate the role of serotonin in depression, se... | BeFree | 17183148 | Detail |
0.011 | Depressive Symptoms | The aim of this study was to investigate the role of serotonin in depression, se... | BeFree | 17183148 | Detail |
0.094 | hyperhomocysteinemia | NA | BeFree,GAD,LHGDN,RGD | Detail | |
0.016 | depressive disorder | The aim of this study was to investigate the role of serotonin in depression, se... | BeFree | 17183148 | Detail |
<0.001 | prostate carcinoma | NA | BeFree | Detail | |
0.002 | hepatopulmonary syndrome | NA | GAD | Detail | |
<0.001 | Progressive Neoplastic Disease | NA | BeFree | Detail | |
0.003 | breast carcinoma | Longitudinal assessment of cognitive changes associated with adjuvant treatment ... | BeFree | 24789331 | Detail |
0.003 | breast carcinoma | APOE genotype, along with other biomarkers, may be used in the future to assist ... | BeFree | 25355028 | Detail |
<0.001 | Vascular rupture | NA | BeFree | Detail | |
<0.001 | Carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Tardive Dyskinesia | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of lymph node | Our study indicates that APOE is a potential indicator of metastatic lung ADC an... | BeFree | 25098600 | Detail |
<0.001 | heavy drinking | NA | BeFree | Detail | |
0.002 | Pregnancy loss | NA | GAD | Detail | |
0.002 | Chronic progressive chorea | NA | GAD | Detail | |
<0.001 | colon carcinoma | NA | BeFree | Detail | |
<0.001 | stomach carcinoma | NA | BeFree | Detail | |
<0.001 | Central neuroblastoma | NA | BeFree | Detail | |
<0.001 | Emotional distress | NA | BeFree | Detail | |
<0.001 | Anxiety state | NA | BeFree | Detail | |
0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
<0.001 | bile duct carcinoma | NA | BeFree | Detail | |
<0.001 | Varicella zoster | NA | BeFree | Detail | |
0.085 | Infarction, Middle Cerebral Artery | NA | GAD,RGD | Detail | |
0.001 | hyperuricemia | Apolipoprotein E gene polymorphisms are associated with primary hyperuricemia in... | BeFree | 25356596 | Detail |
<0.001 | Cardiovascular Pathology | The altered binding to lipids and receptors by ApoE isoforms E2 and E4 results i... | BeFree | 24754513 | Detail |
<0.001 | Hyperlipoproteinemia Type IIa | NA | BeFree | Detail | |
0.001 | Alzheimer Disease, Early Onset | None of these patients had pathogenic mutations, APOE ε4 or other high-risk alle... | BeFree | 26354483 | Detail |
<0.001 | Intracranial Atherosclerosis | NA | BeFree | Detail | |
0.005 | Frontotemporal Lobar Degeneration | NA | BeFree,GAD | Detail | |
0.002 | Memory Loss | NA | BeFree | Detail | |
0.005 | Subarachnoid Hemorrhage, Aneurysmal | NA | GAD | Detail | |
0.003 | CADASIL Syndrome | NA | BeFree,GAD | Detail | |
<0.001 | Carotid Artery Plaque | NA | BeFree | Detail | |
<0.001 | Primary Progressive Nonfluent Aphasia | NA | BeFree | Detail | |
0.001 | Inclusion Body Myopathy, Sporadic | NA | BeFree | Detail | |
0.002 | Lead Poisoning, Nervous System, Adult | NA | GAD | Detail | |
0.007 | Vasospasm, Intracranial | NA | GAD | Detail | |
0.007 | brain infarction | NA | GAD | Detail | |
<0.001 | Acute Cerebrovascular Accidents | NA | BeFree | Detail | |
0.123 | Multiple Sclerosis, Relapsing-Remitting | NA | BeFree,CTD_human,GAD | Detail | |
<0.001 | Dystonia, Primary | NA | BeFree | Detail | |
<0.001 | Hypoxic-Ischemic Encephalopathy | NA | BeFree | Detail | |
0.005 | Hypoxia-Ischemia, Brain | NA | GAD | Detail | |
0.002 | Lupus Vasculitis, Central Nervous System | NA | GAD | Detail | |
<0.001 | thrombocytosis | NA | BeFree | Detail | |
<0.001 | Spots on skin | NA | BeFree | Detail | |
0.005 | Sleep Disorders | NA | BeFree,GAD | Detail | |
0.002 | Blood Coagulation Disorders, Inherited | NA | GAD | Detail | |
<0.001 | Arteriopathic disease | We evaluated whether and to what extent the APOE genotype modifies the relation ... | BeFree | 24946908 | Detail |
0.002 | Cognitive deterioration | NA | BeFree | Detail | |
<0.001 | Fat redistribution | NA | BeFree | Detail | |
0.002 | Endothelial dysfunction | In this review, we focus on the main genes that are epigenetically modified duri... | BeFree | 25433555 | Detail |
0.002 | Endothelial dysfunction | Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunct... | BeFree | 25874925 | Detail |
<0.001 | Cholesterol gallstones | NA | BeFree | Detail | |
0.120 | Drug-Induced Liver Injury | NA | CTD_human | Detail | |
<0.001 | Gallbladder sludge | NA | BeFree | Detail | |
<0.001 | Loss of memory ability | NA | BeFree | Detail | |
0.001 | Psychotic symptom | NA | BeFree | Detail | |
0.002 | traumatic brain injury | NA | GAD | Detail | |
<0.001 | arteriolosclerosis | NA | BeFree | Detail | |
0.002 | Chlamydophila Infections | NA | GAD | Detail | |
0.001 | Cerebral Ischemia | NA | BeFree | Detail | |
<0.001 | transient cerebral ischemia | NA | BeFree | Detail | |
0.003 | ovarian neoplasm | NA | LHGDN | Detail | |
0.002 | Microsatellite Instability | NA | GAD | Detail | |
0.015 | cholecystolithiasis | NA | BeFree,GAD | Detail | |
0.001 | Vascular inflammations | NA | BeFree | Detail | |
0.018 | Ischemic stroke | Apolipoprotein E polymorphisms and ischaemic stroke: a two-center Greek study. | BeFree,GAD | 24471738 | Detail |
0.008 | Acute coronary syndrome | NA | BeFree,GAD | Detail | |
0.003 | Leukoaraiosis | NA | LHGDN | Detail | |
0.005 | coronary restenosis | NA | GAD | Detail | |
0.002 | cervical dystonia | NA | GAD | Detail | |
<0.001 | Tauopathies | NA | BeFree | Detail | |
<0.001 | Progressive multiple sclerosis | NA | BeFree | Detail | |
<0.001 | Drug Resistant Epilepsy | NA | BeFree | Detail | |
<0.001 | Macroangiopathy | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
<0.001 | Myxoid cyst | NA | BeFree | Detail | |
<0.001 | frontal dementia | NA | BeFree | Detail | |
0.001 | Drusen | NA | BeFree | Detail | |
0.003 | Stenosis | NA | LHGDN | Detail | |
0.007 | major depressive disorder | NA | BeFree,GAD | Detail | |
0.040 | Mild cognitive disorder | Our findings demonstrate that higher TC levels are observed long before the clin... | BeFree,GAD | 24241689 | Detail |
0.040 | Mild cognitive disorder | Our findings suggest that SPARE-AD and ADAS-Cog in combination offer the highest... | BeFree,GAD | 24371799 | Detail |
0.040 | Mild cognitive disorder | Using Hotelling's T(2) test, we found significant morphological deformation in A... | BeFree,GAD | 24453132 | Detail |
0.040 | Mild cognitive disorder | Participants were 74 patients with clinically confirmed aMCI (33 APOE ε4 noncarr... | BeFree,GAD | 24749727 | Detail |
0.040 | Mild cognitive disorder | At baseline, older age, APOE-ε4 carriership, lower total cholesterol levels, and... | BeFree,GAD | 24825566 | Detail |
0.040 | Mild cognitive disorder | The analyses were performed in the MCI population and subpopulations enriched by... | BeFree,GAD | 25022537 | Detail |
0.040 | Mild cognitive disorder | We measured RA, anterograde amnesia (AA), brain measures, apolipoprotein-E statu... | BeFree,GAD | 25068664 | Detail |
0.040 | Mild cognitive disorder | Source analysis of spontaneous magnetoencephalograpic activity in healthy aging ... | BeFree,GAD | 25079806 | Detail |
0.040 | Mild cognitive disorder | The interaction of APOE genotype by age in amnestic mild cognitive impairment: a... | BeFree,GAD | 25114090 | Detail |
0.040 | Mild cognitive disorder | Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in a... | BeFree,GAD | 25169676 | Detail |
0.040 | Mild cognitive disorder | Only APOE-inclusive risk scores associated with worse memory and incident MCI/LO... | BeFree,GAD | 25189118 | Detail |
0.040 | Mild cognitive disorder | Influence of the APOE ε4 allele and mild cognitive impairment diagnosis in the d... | BeFree,GAD | 25281603 | Detail |
0.040 | Mild cognitive disorder | APOE and mild cognitive impairment: the Framingham Heart Study. | BeFree,GAD | 25497326 | Detail |
0.040 | Mild cognitive disorder | Combining serum and urine biomarkers in the early diagnosis of mild cognitive im... | BeFree,GAD | 25532446 | Detail |
0.040 | Mild cognitive disorder | We used whole-exome sequencing to identify variants other than APOE associated w... | BeFree,GAD | 25559091 | Detail |
0.040 | Mild cognitive disorder | To investigate the population-based interaction between a biological variable (A... | BeFree,GAD | 25653291 | Detail |
0.040 | Mild cognitive disorder | Five top susceptible single nucleotide polymorphisms (SNPs) in three loci in ZNF... | BeFree,GAD | 25731621 | Detail |
0.040 | Mild cognitive disorder | Predictors of MCI were APOE ε4 allele (hazard ratio [HR] 1.89; p = 0.008), curre... | BeFree,GAD | 25854867 | Detail |
0.002 | Blood pressure finding | NA | GAD | Detail | |
0.005 | Systemic arterial pressure | NA | GAD | Detail | |
<0.001 | Recurrent genital herpes simplex | NA | BeFree | Detail | |
<0.001 | Left ventricular systolic dysfunction | NA | BeFree | Detail | |
<0.001 | Anxiety neurosis (finding) | NA | BeFree | Detail | |
<0.001 | Lipoatrophy | NA | BeFree | Detail | |
<0.001 | Degenerative disorder | NA | BeFree | Detail | |
0.002 | Fetal Nutrition Disorders | NA | GAD | Detail | |
<0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
<0.001 | Peripheral arterial occlusive disease | NA | BeFree | Detail | |
0.002 | Postoperative confusion | NA | BeFree | Detail | |
0.120 | hearing impairment | NA | CTD_human | Detail | |
<0.001 | Arteriosclerosis of aorta | NA | BeFree | Detail | |
0.006 | Cognitive changes | Longitudinal assessment of cognitive changes associated with adjuvant treatment ... | BeFree | 24789331 | Detail |
0.006 | Cognitive changes | We stratified all analyses by race.Using the Modified Mini-Mental State Examinat... | BeFree | 25599330 | Detail |
0.006 | Cognitive changes | General linear mixed-effects models were used to investigate the relationship be... | BeFree | 26245925 | Detail |
0.006 | Cognitive changes | Overall, our results point to education as a protective factor that may help to ... | BeFree | 26408498 | Detail |
0.001 | Vascular lesions | NA | BeFree | Detail | |
0.008 | Mammary Neoplasms | NA | GAD,LHGDN | Detail | |
<0.001 | Hippocampal sclerosis | NA | BeFree | Detail | |
0.043 | Hypertriglyceridemia result | NA | GAD | Detail | |
0.022 | colorectal cancer | NA | BeFree,GAD | Detail | |
0.005 | brain edema | NA | BeFree,GAD | Detail | |
0.002 | Sjogren's syndrome | NA | GAD | Detail | |
0.002 | Chronic Kidney Diseases | NA | BeFree | Detail | |
<0.001 | Mobility Limitation | NA | BeFree | Detail | |
0.120 | Renal Insufficiency | NA | BeFree,CTD_human | Detail | |
<0.001 | Cirrhosis | NA | BeFree | Detail | |
<0.001 | early onset schizophrenia | NA | BeFree | Detail | |
<0.001 | Nephrotic Syndrome, Minimal Change | NA | BeFree | Detail | |
<0.001 | Hyperlipoproteinemia Type IIb | NA | BeFree | Detail | |
<0.001 | Peripheral Arterial Diseases | NA | BeFree | Detail | |
<0.001 | Severe Sepsis | NA | BeFree | Detail | |
<0.001 | Hard drusen | NA | BeFree | Detail | |
<0.001 | Soft drusen | NA | BeFree | Detail | |
<0.001 | INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA | NA | BeFree | Detail | |
<0.001 | Coronary heart disease, susceptibility to, 5 | NA | BeFree | Detail | |
<0.001 | SPEECH-SOUND DISORDER | NA | BeFree | Detail | |
<0.001 | FRAGILE X TREMOR/ATAXIA SYNDROME | NA | BeFree | Detail | |
0.014 | Aural atresia, congenital | Immunohistochemistry was quantified for Aβ42, apoE, apoE E4 and smooth muscle ac... | BeFree | 25195061 | Detail |
0.014 | Aural atresia, congenital | Among individuals with advanced CAA, cSS tends to occur in individuals with rela... | BeFree | 25320098 | Detail |
0.014 | Aural atresia, congenital | This neuropathologically defined CAA cohort suggests that CSS and APOE ε2 are re... | BeFree | 25716356 | Detail |
0.014 | Aural atresia, congenital | Convexal subarachnoid hemorrhage presented an APOE-ɛ2 overrepresentation and CAA... | BeFree | 25735919 | Detail |
<0.001 | NEUROTICISM | NA | BeFree | Detail | |
<0.001 | Myeloproliferative disorder, chronic, with eosinophilia | NA | BeFree | Detail | |
<0.001 | Creutzfeldt-Jakob Disease, Sporadic | NA | BeFree | Detail | |
<0.001 | Pyruvate dehydrogenase E3-binding protein deficiency | NA | BeFree | Detail | |
0.002 | Venous thromboembolism | NA | GAD | Detail | |
<0.001 | Dementia, familial Danish | NA | BeFree | Detail | |
<0.001 | Familial hypobetalipoproteinemia | NA | BeFree | Detail | |
0.001 | Amyotrophic Lateral Sclerosis, Sporadic | NA | BeFree | Detail | |
0.121 | Alzheimer disease 2 | NA | BeFree,CTD_human | Detail | |
<0.001 | INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1 | NA | BeFree | Detail | |
0.120 | Macular Degeneration, Age-Related, 1 | NA | CTD_human | Detail | |
0.126 | coronary artery disease | The aim of this study was to investigate the expression of circulating microRNAs... | BeFree,GAD,LHGDN | 25656948 | Detail |
0.002 | Memory Impairment Adverse Event | NA | GAD | Detail | |
0.006 | Mixed hyperlipidemia (disorder) | NA | BeFree,GAD | Detail | |
<0.001 | Daytime somnolence | NA | BeFree | Detail | |
0.005 | liver carcinoma | NA | BeFree,LHGDN | Detail | |
0.002 | Chronic kidney disease stage 5 | Association of apolipoprotein E gene polymorphism with end-stage renal disease a... | BeFree | 25155022 | Detail |
<0.001 | Iatrogenic Creutzfeldt-Jakob disease | NA | BeFree | Detail | |
<0.001 | Pediatric Obesity | NA | BeFree | Detail | |
<0.001 | clinical depression | NA | BeFree | Detail | |
0.007 | WARFARIN SENSITIVITY (disorder) | NA | GAD | Detail | |
0.494 | Lipoprotein glomerulopathy | Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new ... | BeFree,CLINVAR,CTD_human,GAD,ORPHANET,UNIPROT | 25300642 | Detail |
<0.001 | Hypothalamic-pituitary-adrenal axis dysfunction | NA | BeFree | Detail | |
0.440 | Alzheimer's disease | The interaction between PON1 genes (rs662 and rs85460) and ApoE genes showed syn... | BeFree | 24965284 | Detail |
<0.001 | Steatohepatitis | Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atheroscleros... | BeFree | 25392542 | Detail |
0.071 | Dementia, Vascular | The interaction between PON1 genes (rs662 and rs85460) and ApoE genes showed syn... | BeFree | 24965284 | Detail |
<0.001 | Combined hyperlipidemia | NA | BeFree | Detail | |
<0.001 | Alcoholic Steatohepatitis | NA | BeFree | Detail | |
<0.001 | Executive dysfunction | NA | BeFree | Detail | |
0.002 | Weight Gain Adverse Event | NA | GAD | Detail | |
0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
<0.001 | Glycogen storage disease type Ia | NA | BeFree | Detail | |
0.002 | Recurrent pregnancy loss | NA | GAD | Detail | |
<0.001 | Visuospatial deficit | NA | BeFree | Detail | |
0.003 | Amyloid angiopathy | NA | BeFree | Detail | |
<0.001 | Acquired CJD | NA | BeFree | Detail | |
0.016 | Plaque, Amyloid | NA | BeFree,GAD | Detail | |
0.120 | Plaque, Atherosclerotic | NA | CTD_human | Detail | |
0.051 | Cerebral Hemorrhage | NA | GAD,LHGDN | Detail | |
<0.001 | Early-Stage Breast Carcinoma | Apolipoprotein E genotype and cognitive function in postmenopausal women with ea... | BeFree | 25355028 | Detail |
<0.001 | hyperalphalipoproteinemia 1 | NA | BeFree | Detail | |
<0.001 | Parkinson disease, late-onset | Cognitive, neuropsychiatric, and motor features associated with apolipoprotein E... | BeFree | 24646656 | Detail |
0.005 | Hypotension Adverse Event | NA | GAD | Detail | |
0.009 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
<0.001 | Single Ventricle Defect | NA | BeFree | Detail | |
<0.001 | Prodromal Period | NA | BeFree | Detail | |
<0.001 | Mild dementia | NA | BeFree | Detail | |
<0.001 | Severe dementia | NA | BeFree | Detail | |
0.002 | Homocysteinemia | NA | BeFree | Detail | |
0.002 | Mixed dementia | NA | BeFree | Detail | |
<0.001 | Progressive cGVHD | NA | BeFree | Detail | |
<0.001 | Dementia due to Alzheimer's disease (disorder) | We included 210 consecutive patients with late-onset AD to investigate whether e... | BeFree | 24596166 | Detail |
0.008 | Infection | NA | LHGDN | Detail | |
0.002 | GRN-related frontotemporal dementia | NA | BeFree | Detail | |
<0.001 | Dysexecutive syndrome | Sixty per cent of patients with behavioural Alzheimer's disease and 40% of those... | BeFree | 26141491 | Detail |
0.005 | Psychomotor Agitation | NA | GAD | Detail | |
<0.001 | abetalipoproteinemia | NA | BeFree | Detail | |
0.002 | Congenital Abnormality | NA | GAD | Detail | |
0.071 | Dementia, Vascular | This study assessed the roles of Tau gene short tandem repeats (STRs) nested wit... | BeFree | 22176350 | Detail |
0.122 | Spontaneous abortion | NA | CTD_human,GAD | Detail | |
0.003 | acquired immunodeficiency syndrome | NA | BeFree,GAD | Detail | |
<0.001 | acromegaly | NA | BeFree | Detail | |
<0.001 | Acute Disease | NA | BeFree | Detail | |
<0.001 | acute pancreatitis | NA | BeFree | Detail | |
0.120 | adenocarcinoma | NA | BeFree,CTD_human | Detail | |
0.005 | adenoma | NA | BeFree,GAD | Detail | |
<0.001 | Adrenal Cortex Diseases | Mean expression of APOE and TOMM40 mRNA levels were higher in VL homozygotes com... | BeFree | 24439168 | Detail |
0.006 | AIDS Dementia Complex | NA | BeFree,GAD | Detail | |
0.002 | Albuminuria | NA | GAD | Detail | |
0.002 | Alcohol Amnestic Disorder | NA | GAD | Detail | |
0.013 | Alcoholic Intoxication, Chronic | NA | BeFree,GAD | Detail | |
0.014 | Amnesia | NA | BeFree,GAD | Detail | |
<0.001 | Post-traumatic amnesia | NA | BeFree | Detail | |
<0.001 | retrograde amnesia | We measured RA, anterograde amnesia (AA), brain measures, apolipoprotein-E statu... | BeFree | 25068664 | Detail |
0.128 | amyloidosis | APOE ε4, the major genetic risk factor for late-onset AD, has been associated wi... | BeFree,CTD_human,GAD | 24929969 | Detail |
0.017 | amyotrophic lateral sclerosis | Lack of association between APOE gene polymorphisms and amyotrophic lateral scle... | BeFree,GAD | 24918518 | Detail |
0.017 | amyotrophic lateral sclerosis | Treatment of adult microglia with apolipoprotein E suppressed the M0-homeostatic... | BeFree,GAD | 25381879 | Detail |
<0.001 | Cooley's anemia | NA | BeFree | Detail | |
0.005 | Anemia, Sickle Cell | NA | BeFree,GAD | Detail | |
0.002 | Aneurysm | NA | BeFree | Detail | |
0.012 | Angina Pectoris | NA | GAD | Detail | |
<0.001 | Angina Pectoris, Variant | NA | BeFree | Detail | |
0.005 | Angina, Unstable | NA | BeFree,GAD | Detail | |
<0.001 | Anomia | NA | BeFree | Detail | |
0.005 | Anoxia | NA | GAD,LHGDN | Detail | |
0.002 | Anxiety Disorders | NA | BeFree | Detail | |
0.002 | aortic aneurysm | NA | BeFree | Detail | |
<0.001 | Aortic Rupture | NA | BeFree | Detail | |
0.006 | aortic valve stenosis | NA | BeFree,GAD,LHGDN | Detail | |
0.005 | aphasia | NA | GAD | Detail | |
<0.001 | Apraxias | The presence of apraxia in AD is related to dementia severity and APOE ε4. | BeFree | 24603451 | Detail |
0.207 | arteriosclerosis | Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis ... | BeFree,CTD_human,GAD | 24722330 | Detail |
0.207 | arteriosclerosis | Apolipoprotein A1 (ApoA1) and apolipoprotein E (ApoE) mimetic peptides have attr... | BeFree,CTD_human,GAD | 25036240 | Detail |
0.207 | arteriosclerosis | The objective of this study was to investigate the effect of Lactobacillus acido... | BeFree,CTD_human,GAD | 25261526 | Detail |
0.207 | arteriosclerosis | Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ ... | BeFree,CTD_human,GAD | 25377726 | Detail |
0.207 | arteriosclerosis | Finally, we studied the effect of 3BDO on oxLDL-altered PDI protein level in apo... | BeFree,CTD_human,GAD | 25389050 | Detail |
0.207 | arteriosclerosis | The serum levels of atherosclerosis-related inflammatory factors in ApoE-/- mice... | BeFree,CTD_human,GAD | 25889019 | Detail |
0.207 | arteriosclerosis | Here, we evaluated the contribution of CD39 to atherogenesis in the apolipoprote... | BeFree,CTD_human,GAD | 26121751 | Detail |
0.207 | arteriosclerosis | IRF2BP2-deficient macrophages worsened atherosclerosis in irradiated low-density... | BeFree,CTD_human,GAD | 26195219 | Detail |
0.009 | Congenital arteriovenous malformation | NA | BeFree,GAD,LHGDN | Detail | |
0.006 | rheumatoid arthritis | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | asthma | NA | BeFree | Detail | |
0.001 | Astrocytoma | NA | BeFree | Detail | |
0.302 | atherosclerosis | Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis ... | BeFree,CTD_human,GAD,LHGDN | 24722330 | Detail |
0.302 | atherosclerosis | Apolipoprotein A1 (ApoA1) and apolipoprotein E (ApoE) mimetic peptides have attr... | BeFree,CTD_human,GAD,LHGDN | 25036240 | Detail |
0.302 | atherosclerosis | The objective of this study was to investigate the effect of Lactobacillus acido... | BeFree,CTD_human,GAD,LHGDN | 25261526 | Detail |
0.302 | atherosclerosis | Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ ... | BeFree,CTD_human,GAD,LHGDN | 25377726 | Detail |
0.302 | atherosclerosis | Finally, we studied the effect of 3BDO on oxLDL-altered PDI protein level in apo... | BeFree,CTD_human,GAD,LHGDN | 25389050 | Detail |
0.302 | atherosclerosis | The serum levels of atherosclerosis-related inflammatory factors in ApoE-/- mice... | BeFree,CTD_human,GAD,LHGDN | 25889019 | Detail |
0.302 | atherosclerosis | Here, we evaluated the contribution of CD39 to atherogenesis in the apolipoprote... | BeFree,CTD_human,GAD,LHGDN | 26121751 | Detail |
0.302 | atherosclerosis | IRF2BP2-deficient macrophages worsened atherosclerosis in irradiated low-density... | BeFree,CTD_human,GAD,LHGDN | 26195219 | Detail |
0.005 | atrial fibrillation | NA | GAD | Detail | |
<0.001 | Tooth Attrition | NA | BeFree | Detail | |
0.006 | autistic disorder | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Bacterial Infections | NA | BeFree | Detail | |
0.002 | Chronic Kidney Diseases | The chi-square test and multivariable logistic regression analysis with adjustme... | BeFree | 19406964 | Detail |
0.004 | Mental disorders | NA | BeFree,GAD | Detail | |
0.003 | Behcet Syndrome | NA | BeFree,GAD | Detail | |
0.005 | beta thalassemia | NA | BeFree,GAD | Detail | |
0.003 | Bile Duct Neoplasms | NA | LHGDN | Detail | |
0.002 | Biliary Tract Neoplasm | NA | GAD | Detail | |
<0.001 | bipolar disorder | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of urinary bladder | NA | GAD | Detail | |
<0.001 | Blood Coagulation Disorders | NA | BeFree | Detail | |
0.002 | Metabolic Bone Disorder | NA | GAD | Detail | |
0.002 | Brain Damage, Chronic | NA | GAD | Detail | |
0.003 | Brain Diseases | NA | BeFree,GAD | Detail | |
<0.001 | Brain Neoplasms | NA | BeFree | Detail | |
0.010 | Malignant neoplasm of breast | Longitudinal assessment of cognitive changes associated with adjuvant treatment ... | BeFree,GAD | 24789331 | Detail |
0.010 | Malignant neoplasm of breast | APOE genotype, along with other biomarkers, may be used in the future to assist ... | BeFree,GAD | 25355028 | Detail |
0.005 | calcinosis | NA | GAD | Detail | |
0.002 | cutaneous candidiasis | NA | GAD | Detail | |
0.002 | Carbon Monoxide Poisoning | NA | GAD | Detail | |
<0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
<0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
0.003 | renal cell carcinoma | NA | BeFree,GAD | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We included 210 consecutive patients with late-onset AD to investigate whether education, gender, na... | DisGeNET | Detail |
The role of apolipoprotein E in neurodegeneration and cardiovascular disease. | DisGeNET | Detail |
The apoE polymorphism affects the serum lipoprotein levels, and the ESRD patients who are e4 and e2 ... | DisGeNET | Detail |
The APOE gene stands out as an exception, given that it has been identified as being relevant in CVD... | DisGeNET | Detail |
SN gene therapy exerts beneficial effects in cardiovascular animal models in Apo E(-/-) mice without... | DisGeNET | Detail |
The present meta-analysis confirms that, besides its previously documented influence on Alzheimer's ... | DisGeNET | Detail |
The results presented demonstrate that the association between ApoE gene and CVD may be modulated by... | DisGeNET | Detail |
Our findings provide the scientific rationale supporting a novel clinical application for APOE genot... | DisGeNET | Detail |
The analysis showed that Braak stages III to VI were significantly predicted by having 1 or more APO... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The Chi-square test, multivariable logistic regression analysis with adjustment for covariates, as w... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of the ApoE gene polymorphism and dietary factors with cerebral infarction and circulati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings suggest that genetic variations in one of the sequences regulating the expression of AP... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
APOE genotyping was performed to evaluate the allele and genotype frequencies in 378 Saudi subjects ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Apolipoprotein E polymorphism and colorectal neoplasm: results from a meta-analysis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Common variants of apolipoprotein E and cholesteryl ester transport protein genes in male patients w... | DisGeNET | Detail |
A systematic review and meta-analysis of 130,000 individuals shows smoking does not modify the assoc... | DisGeNET | Detail |
Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher... | DisGeNET | Detail |
Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influen... | DisGeNET | Detail |
Review: Apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in Asian populations. | DisGeNET | Detail |
Common variants of apolipoprotein E and cholesteryl ester transport protein genes in male patients w... | DisGeNET | Detail |
A systematic review and meta-analysis of 130,000 individuals shows smoking does not modify the assoc... | DisGeNET | Detail |
Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher... | DisGeNET | Detail |
Review: Apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in Asian populations. | DisGeNET | Detail |
APOE genotyping was performed to evaluate the allele and genotype frequencies in 378 Saudi subjects ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
As neurodegenerative processes are implicated in swallowing dysfunction, we hypothesized that the pr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene... | DisGeNET | Detail |
High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with... | DisGeNET | Detail |
The presence of apraxia in AD is related to dementia severity and APOE ε4. | DisGeNET | Detail |
To explore apolipoprotein E gene variants distribution among the patients of Alzheimer's disease and... | DisGeNET | Detail |
Results indicate that the relationship between sedentary time and CBF in the left hippocampus differ... | DisGeNET | Detail |
The MCI subjects who developed dementia were more likely to carry at least one copy of the APOE ε4 a... | DisGeNET | Detail |
Association of apolipoprotein E-e4 and dementia declines with age. | DisGeNET | Detail |
The cluster-derived normal group had significantly fewer APOE ε4 carriers and fewer who progressed t... | DisGeNET | Detail |
Apolipoprotein E ε4 (APOE ε4) is a risk factor for β-amyloid deposition in Alzheimer's disease demen... | DisGeNET | Detail |
The levels of miR‑193b, exosomal miR‑193b, Aβ, tau, p‑tau, HCY and APOE in samples from APP/PS1 doub... | DisGeNET | Detail |
Cognitively healthy NDFAM showed a higher net cognitive gain after CS, as reflected in their MoCA sc... | DisGeNET | Detail |
Increased WMH volume was associated with increased frequency of dementia irrespective of APOE ε4 sta... | DisGeNET | Detail |
We assessed relative telomere length and apolipoprotein E genotype in subjects with dementia (n=70) ... | DisGeNET | Detail |
Influence of socio-demographic features and apolipoprotein E epsilon 4 expression on the prevalence ... | DisGeNET | Detail |
We included 209 consecutive late-onset AD patients to find out which factors among educational level... | DisGeNET | Detail |
Apolipoprotein E (APOE) ε4 is an established risk factor for cognitive decline and the development o... | DisGeNET | Detail |
Mediation analysis was used to estimate the direct and indirect effects of APOE alleles on AD pathol... | DisGeNET | Detail |
There was a synergistic interaction between depression or apathy and APOE ε4 in further elevating th... | DisGeNET | Detail |
This article considers APOE ϵ4 effects on cognition in people without dementia, the extent to which ... | DisGeNET | Detail |
The allele frequency of APOE ε4 varies both across and within populations, and the size of the effec... | DisGeNET | Detail |
Subgroup analyses indicated that (1) the significantly increased risk of AD from current smoking was... | DisGeNET | Detail |
We have also established novel methods to express apoE isoforms in mouse brain to study apoE-related... | DisGeNET | Detail |
Among persons without dementia, the prevalence of cerebral amyloid pathology as determined by positr... | DisGeNET | Detail |
These findings indicate the potential clinical utility of amyloid imaging for differential diagnosis... | DisGeNET | Detail |
Eleven patients with dementia had apolipoprotein E 4 (ApoE4) and R47H genotypes. | DisGeNET | Detail |
Interaction of Apolipoprotein E Genotypes, Lifestyle Factors and Future Risk of Dementia-Related Mor... | DisGeNET | Detail |
NA | DisGeNET | Detail |
There was a synergistic interaction between depression or apathy and APOE ε4 in further elevating th... | DisGeNET | Detail |
Association between apolipoprotein E gene polymorphism and depression. | DisGeNET | Detail |
There was a synergistic interaction between depression or apathy and APOE ε4 in further elevating th... | DisGeNET | Detail |
Association between apolipoprotein E gene polymorphism and depression. | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results suggest that previous findings of an association of the TOMM40 short allele with bette... | DisGeNET | Detail |
These results suggest that previous findings of an association of the TOMM40 short allele with bette... | DisGeNET | Detail |
Among black APOE ε4 carriers, the strongest predictors of cognitive resilience were, in relative ord... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Type 2 diabetes is associated with increased expression of APOE, BAX, MMP1, NFKB1, PDGFB, SPP1, and ... | DisGeNET | Detail |
We assessed relative telomere length and apolipoprotein E genotype in subjects with dementia (n=70) ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Apo E gene polymorphism affects development of type 2 diabetic nephropathy in Asian populations, esp... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Similar efforts are occurring in an extended Colombian family with a PSEN1 mutation, in APOE ε4 homo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates he... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Trade-offs in the effects of the apolipoprotein E polymorphism on risks of diseases of the heart, ca... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These data replicate and strengthen prior findings of the lack of association between ApoE ε4 and co... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Slovenian children born between 1989 and 2009 (n = 272) with TC >6 mmol/l (231.7 mg/dl) or >5 mmol/l... | DisGeNET | Detail |
Metaanalysis of the weighted 6-SNP score, on the basis of polymorphisms in CELSR2 (cadherin, EGF LAG... | DisGeNET | Detail |
Similar to its existing use in the diagnosis of monogenic dyslipidemias such as familial hypercholes... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Primary genetic investigation of a hyperlipidemia model: molecular characteristics and variants of t... | DisGeNET | Detail |
Association of apolipoprotein E gene polymorphism with end-stage renal disease and hyperlipidemia in... | DisGeNET | Detail |
We evaluated whether and to what extent the APOE genotype modifies the relation between adiposity an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hypertension moderates the effect of APOE on 21-year cognitive trajectories. | DisGeNET | Detail |
In conclusion, the results of this epistasis study indicated significant association between the Apo... | DisGeNET | Detail |
These results provide tentative evidence that APOE genotype moderates the association between high b... | DisGeNET | Detail |
Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: effect of hypertensi... | DisGeNET | Detail |
Predictors of MCI were APOE ε4 allele (hazard ratio [HR] 1.89; p = 0.008), current depressive sympto... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Genetic association of apolipoprotein E polymorphisms with inflammatory bowel disease. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our meta-analysis supports that the ApoE ε2 allele and ACACB rs2268388 C>T might act as promotion fa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of apolipoprotein E gene polymorphism with end-stage renal disease and hyperlipidemia in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Meta-analysis of apolipoprotein E gene polymorphism and susceptibility of myocardial infarction. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Secretomes are a potential source of molecular targets for cancer therapies and indicate that APOE i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Among PD patients without dementia, the APOE ε4 allele was only associated with lower performance on... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Increased cholesterol biosynthesis, elevated PCSK9 levels and reduced APOE mRNA expression newly fou... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In each case, a single gene is represented in a plurality of epistatic interactions, apolipoprotein ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The KLC1 and APOE genes may be novel susceptibility genes for age-related cataracts. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The Number of Cysteine Residues per Mole in Apolipoprotein E Is Associated With the Severity of PTSD... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The data about apolipoprotein E gene (APOE) genotype and the risk of stroke are inconsistent. | DisGeNET | Detail |
Association of the ApoE gene polymorphism and dietary factors with cerebral infarction and circulati... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analyses also considered APOE genotype and tremor- vs. rigidity-dominant phenotype. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients w... | DisGeNET | Detail |
APOE genotype was significantly associated with performance on several different tests of cognitive ... | DisGeNET | Detail |
Predictors of MCI were APOE ε4 allele (hazard ratio [HR] 1.89; p = 0.008), current depressive sympto... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Apolipoprotein E and protection against hepatitis E viral infection in American non-Hispanic blacks. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To gain insight into different cerebral amyloid angiopathy (CAA) phenotypes and mechanisms, we inves... | DisGeNET | Detail |
APOE ε4 is associated with recurrent ICH in nonlobar brain regions, providing further evidence for i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Apolipoprotein E and protection against hepatitis E viral infection in American non-Hispanic blacks. | DisGeNET | Detail |
APOE [Latin Small Letter Open E]4 is a major risk factor for late-onset Alzheimer disease, a progres... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Reduced brain-derived neurotrophic factor (BDNF) signaling is considered as a pathogenic event in ea... | DisGeNET | Detail |
There was a synergistic interaction between depression or apathy and APOE ε4 in further elevating th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Predictors of MCI were APOE ε4 allele (hazard ratio [HR] 1.89; p = 0.008), current depressive sympto... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
APOE ɛ4 was associated with atrophic hippocampal volume in MRI markers, increased cerebral amyloid d... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influen... | DisGeNET | Detail |
Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ... | DisGeNET | Detail |
Secretomes are a potential source of molecular targets for cancer therapies and indicate that APOE i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
No renal phenotype in human phospholipid transfer protein transgenic apolipoprotein E deficient mice... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Seven patients had high levels of PrP, low Aβ42, high APOE-4, and 40% nerve cell loss, suggesting th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The apolipoprotein E ε4 (ApoE ε4) allele not only represents the strongest single genetic risk facto... | DisGeNET | Detail |
Compared with the stable memory trajectory, high Αβ (relative risk ratio [RRR] = 2.1), and lower Min... | DisGeNET | Detail |
In conclusion, behavioural Alzheimer's disease presentations are characterized by a milder and more ... | DisGeNET | Detail |
We measured RA, anterograde amnesia (AA), brain measures, apolipoprotein-E status (ApoE), and conver... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
It was therefore investigated whether the association between load of WMHs and brain atrophy measure... | DisGeNET | Detail |
This study evaluates the individual, as well as relative and joint value of indices obtained from ma... | DisGeNET | Detail |
Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in ... | DisGeNET | Detail |
Only 1 FTD patient (homozygous for apolipoprotein E ε4) displayed high cortical (18)F-florbetapir re... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Perhaps less well known, and certainly less well characterized, is that this ϵ4 variant of the APOE ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A lower EF performance in cognitively intact older APOE ε4 allele carriers might be related to an ea... | DisGeNET | Detail |
APOE gene polymorphism and risk of coronary stenosis in Pakistani population. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia. | DisGeNET | Detail |
Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolip... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Apolipoprotein E gene polymorphisms in relation to chronic periodontitis, periodontopathic bacteria,... | DisGeNET | Detail |
We report the association between ApoE 4 homozygous genotype and self-reported oropharyngeal dysphag... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Polymorphisms in the APOE gene and the location of retinal fluid in eyes with neovascular age-relate... | DisGeNET | Detail |
To study whether presenilin 1 (PSEN1), apolipoprotein E (APOE), and kinesin light chain 1 (KLC1) gen... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
APOE [Latin Small Letter Open E]4 is a major risk factor for late-onset Alzheimer disease, a progres... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Only 1 FTD patient (homozygous for apolipoprotein E ε4) displayed high cortical (18)F-florbetapir re... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In linear mixed models, controlling for age, gender, education, and apolipoprotein E status, subject... | DisGeNET | Detail |
Apolipoprotein E (ApoE) is the most well-described genetic risk factor for Alzheimer's disease and n... | DisGeNET | Detail |
Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in ... | DisGeNET | Detail |
The alternative prodrome hypothesis predicts that the APOE-ε4 allele would be associated with longit... | DisGeNET | Detail |
The combined effects of metabolic syndrome and the apolipoprotein E and CYP46 genotypes on the risk ... | DisGeNET | Detail |
Age, APOE ε4, and decline in intellectually and socially stimulating recreational activity from mid ... | DisGeNET | Detail |
Hypertension moderated the effects of APOE ε4 on the rate of change for cognitive flexibility, such ... | DisGeNET | Detail |
Deploying a between-sibling design that allows quasi-experimental variation in genotype and educatio... | DisGeNET | Detail |
Moreover, the interaction of APOE by age on brain morphology may accelerate the pathological progres... | DisGeNET | Detail |
Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher... | DisGeNET | Detail |
APOE genotype, along with other biomarkers, may be used in the future to assist nurses in identifyin... | DisGeNET | Detail |
Influence of socio-demographic features and apolipoprotein E epsilon 4 expression on the prevalence ... | DisGeNET | Detail |
Higher UACR values were significantly associated with cognitive dysfunction in the general Korean po... | DisGeNET | Detail |
Apolipoprotein E (ApoE) ε4 allele is a known genetic risk factor for AD, which not only predisposes ... | DisGeNET | Detail |
APOE allele might play a role in the occurrence of cognitive impairment after mTBI. | DisGeNET | Detail |
Although APOE ε4 carriers are at high risk for cognitive decline, our findings suggest possible inte... | DisGeNET | Detail |
Interactive effect of APOE genotype and blood pressure on cognitive decline: the PATH through life s... | DisGeNET | Detail |
Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline. | DisGeNET | Detail |
The ε4 allele of apolipoprotein E (APOE ε4) is a well-established risk factor for Alzheimer's diseas... | DisGeNET | Detail |
Among persons without dementia, the prevalence of cerebral amyloid pathology as determined by positr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Analysis of the expression and polymorphism of APOE, HSP, BDNF, and GRIN2B genes associated with the... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia a... | DisGeNET | Detail |
Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene... | DisGeNET | Detail |
High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with... | DisGeNET | Detail |
The presence of apraxia in AD is related to dementia severity and APOE ε4. | DisGeNET | Detail |
To explore apolipoprotein E gene variants distribution among the patients of Alzheimer's disease and... | DisGeNET | Detail |
Results indicate that the relationship between sedentary time and CBF in the left hippocampus differ... | DisGeNET | Detail |
The MCI subjects who developed dementia were more likely to carry at least one copy of the APOE ε4 a... | DisGeNET | Detail |
Association of apolipoprotein E-e4 and dementia declines with age. | DisGeNET | Detail |
The cluster-derived normal group had significantly fewer APOE ε4 carriers and fewer who progressed t... | DisGeNET | Detail |
Apolipoprotein E ε4 (APOE ε4) is a risk factor for β-amyloid deposition in Alzheimer's disease demen... | DisGeNET | Detail |
The levels of miR‑193b, exosomal miR‑193b, Aβ, tau, p‑tau, HCY and APOE in samples from APP/PS1 doub... | DisGeNET | Detail |
Cognitively healthy NDFAM showed a higher net cognitive gain after CS, as reflected in their MoCA sc... | DisGeNET | Detail |
Increased WMH volume was associated with increased frequency of dementia irrespective of APOE ε4 sta... | DisGeNET | Detail |
We assessed relative telomere length and apolipoprotein E genotype in subjects with dementia (n=70) ... | DisGeNET | Detail |
Influence of socio-demographic features and apolipoprotein E epsilon 4 expression on the prevalence ... | DisGeNET | Detail |
We included 209 consecutive late-onset AD patients to find out which factors among educational level... | DisGeNET | Detail |
Apolipoprotein E (APOE) ε4 is an established risk factor for cognitive decline and the development o... | DisGeNET | Detail |
Mediation analysis was used to estimate the direct and indirect effects of APOE alleles on AD pathol... | DisGeNET | Detail |
There was a synergistic interaction between depression or apathy and APOE ε4 in further elevating th... | DisGeNET | Detail |
This article considers APOE ϵ4 effects on cognition in people without dementia, the extent to which ... | DisGeNET | Detail |
The allele frequency of APOE ε4 varies both across and within populations, and the size of the effec... | DisGeNET | Detail |
Subgroup analyses indicated that (1) the significantly increased risk of AD from current smoking was... | DisGeNET | Detail |
We have also established novel methods to express apoE isoforms in mouse brain to study apoE-related... | DisGeNET | Detail |
Among persons without dementia, the prevalence of cerebral amyloid pathology as determined by positr... | DisGeNET | Detail |
These findings indicate the potential clinical utility of amyloid imaging for differential diagnosis... | DisGeNET | Detail |
Eleven patients with dementia had apolipoprotein E 4 (ApoE4) and R47H genotypes. | DisGeNET | Detail |
Interaction of Apolipoprotein E Genotypes, Lifestyle Factors and Future Risk of Dementia-Related Mor... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The relationship between obstructive sleep apnea syndrome and apolipoprotein E genetic variants. | DisGeNET | Detail |
NA | DisGeNET | Detail |
APOE [Latin Small Letter Open E]4 is a major risk factor for late-onset Alzheimer disease, a progres... | DisGeNET | Detail |
We included 210 consecutive patients with late-onset AD to investigate whether education, gender, na... | DisGeNET | Detail |
In this regard, the GHRH-GH-IGF-1/Insulin, TOR-S6K1,NAD(+)-Sirtuin, P53, Klotho and APOE pathways ha... | DisGeNET | Detail |
Here we focused on long-living participants of the Long Life Family Study (LLFS), their offspring, a... | DisGeNET | Detail |
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for geno... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mean expression of APOE and TOMM40 mRNA levels were higher in VL homozygotes compared with S homozyg... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to investigate the role of serotonin in depression, searching for associat... | DisGeNET | Detail |
The aim of this study was to investigate the role of serotonin in depression, searching for associat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to investigate the role of serotonin in depression, searching for associat... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: t... | DisGeNET | Detail |
APOE genotype, along with other biomarkers, may be used in the future to assist nurses in identifyin... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our study indicates that APOE is a potential indicator of metastatic lung ADC and that secretomes ma... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Apolipoprotein E gene polymorphisms are associated with primary hyperuricemia in a Chinese populatio... | DisGeNET | Detail |
The altered binding to lipids and receptors by ApoE isoforms E2 and E4 results in an elevated risk f... | DisGeNET | Detail |
NA | DisGeNET | Detail |
None of these patients had pathogenic mutations, APOE ε4 or other high-risk alleles associated with ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We evaluated whether and to what extent the APOE genotype modifies the relation between adiposity an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this review, we focus on the main genes that are epigenetically modified during the atherogenic p... | DisGeNET | Detail |
Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotei... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Apolipoprotein E polymorphisms and ischaemic stroke: a two-center Greek study. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings demonstrate that higher TC levels are observed long before the clinical manifestation o... | DisGeNET | Detail |
Our findings suggest that SPARE-AD and ADAS-Cog in combination offer the highest predictive power of... | DisGeNET | Detail |
Using Hotelling's T(2) test, we found significant morphological deformation in APOE e4 carriers rela... | DisGeNET | Detail |
Participants were 74 patients with clinically confirmed aMCI (33 APOE ε4 noncarriers, 26 heterozygou... | DisGeNET | Detail |
At baseline, older age, APOE-ε4 carriership, lower total cholesterol levels, and stroke were associa... | DisGeNET | Detail |
The analyses were performed in the MCI population and subpopulations enriched by apolipoprotein E4 (... | DisGeNET | Detail |
We measured RA, anterograde amnesia (AA), brain measures, apolipoprotein-E status (ApoE), and conver... | DisGeNET | Detail |
Source analysis of spontaneous magnetoencephalograpic activity in healthy aging and mild cognitive i... | DisGeNET | Detail |
The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphom... | DisGeNET | Detail |
Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cogniti... | DisGeNET | Detail |
Only APOE-inclusive risk scores associated with worse memory and incident MCI/LOAD. | DisGeNET | Detail |
Influence of the APOE ε4 allele and mild cognitive impairment diagnosis in the disruption of the MEG... | DisGeNET | Detail |
APOE and mild cognitive impairment: the Framingham Heart Study. | DisGeNET | Detail |
Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolve... | DisGeNET | Detail |
We used whole-exome sequencing to identify variants other than APOE associated with the rate of hipp... | DisGeNET | Detail |
To investigate the population-based interaction between a biological variable (APOE ε4), neuropsychi... | DisGeNET | Detail |
Five top susceptible single nucleotide polymorphisms (SNPs) in three loci in ZNF827, KDM2B and NANP ... | DisGeNET | Detail |
Predictors of MCI were APOE ε4 allele (hazard ratio [HR] 1.89; p = 0.008), current depressive sympto... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: t... | DisGeNET | Detail |
We stratified all analyses by race.Using the Modified Mini-Mental State Examination scores, we asses... | DisGeNET | Detail |
General linear mixed-effects models were used to investigate the relationship between baseline cereb... | DisGeNET | Detail |
Overall, our results point to education as a protective factor that may help to postpone cognitive c... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunohistochemistry was quantified for Aβ42, apoE, apoE E4 and smooth muscle actin, and CAA-associa... | DisGeNET | Detail |
Among individuals with advanced CAA, cSS tends to occur in individuals with relatively lower CMB cou... | DisGeNET | Detail |
This neuropathologically defined CAA cohort suggests that CSS and APOE ε2 are related to the hemorrh... | DisGeNET | Detail |
Convexal subarachnoid hemorrhage presented an APOE-ɛ2 overrepresentation and CAAo had an APOE-ɛ4 ove... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to investigate the expression of circulating microRNAs (miRNAs) in apolipo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of apolipoprotein E gene polymorphism with end-stage renal disease and hyperlipidemia in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new Chinese patient with... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The interaction between PON1 genes (rs662 and rs85460) and ApoE genes showed synergistic epistasis i... | DisGeNET | Detail |
Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates he... | DisGeNET | Detail |
The interaction between PON1 genes (rs662 and rs85460) and ApoE genes showed synergistic epistasis i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast can... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Cognitive, neuropsychiatric, and motor features associated with apolipoprotein E ε4 allele in a samp... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We included 210 consecutive patients with late-onset AD to investigate whether education, gender, na... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Sixty per cent of patients with behavioural Alzheimer's disease and 40% of those with the dysexecuti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study assessed the roles of Tau gene short tandem repeats (STRs) nested within intron 1 (rs5820... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mean expression of APOE and TOMM40 mRNA levels were higher in VL homozygotes compared with S homozyg... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We measured RA, anterograde amnesia (AA), brain measures, apolipoprotein-E status (ApoE), and conver... | DisGeNET | Detail |
APOE ε4, the major genetic risk factor for late-onset AD, has been associated with smaller volume in... | DisGeNET | Detail |
Lack of association between APOE gene polymorphisms and amyotrophic lateral sclerosis: a comprehensi... | DisGeNET | Detail |
Treatment of adult microglia with apolipoprotein E suppressed the M0-homeostatic unique microglia si... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The presence of apraxia in AD is related to dementia severity and APOE ε4. | DisGeNET | Detail |
Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-... | DisGeNET | Detail |
Apolipoprotein A1 (ApoA1) and apolipoprotein E (ApoE) mimetic peptides have attracted attention due ... | DisGeNET | Detail |
The objective of this study was to investigate the effect of Lactobacillus acidophilus ATCC 4356 on ... | DisGeNET | Detail |
Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influen... | DisGeNET | Detail |
Finally, we studied the effect of 3BDO on oxLDL-altered PDI protein level in apolipoprotein E(-/-) m... | DisGeNET | Detail |
The serum levels of atherosclerosis-related inflammatory factors in ApoE-/- mice were measured by mo... | DisGeNET | Detail |
Here, we evaluated the contribution of CD39 to atherogenesis in the apolipoprotein E-deficient (ApoE... | DisGeNET | Detail |
IRF2BP2-deficient macrophages worsened atherosclerosis in irradiated low-density lipoprotein recepto... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-... | DisGeNET | Detail |
Apolipoprotein A1 (ApoA1) and apolipoprotein E (ApoE) mimetic peptides have attracted attention due ... | DisGeNET | Detail |
The objective of this study was to investigate the effect of Lactobacillus acidophilus ATCC 4356 on ... | DisGeNET | Detail |
Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influen... | DisGeNET | Detail |
Finally, we studied the effect of 3BDO on oxLDL-altered PDI protein level in apolipoprotein E(-/-) m... | DisGeNET | Detail |
The serum levels of atherosclerosis-related inflammatory factors in ApoE-/- mice were measured by mo... | DisGeNET | Detail |
Here, we evaluated the contribution of CD39 to atherogenesis in the apolipoprotein E-deficient (ApoE... | DisGeNET | Detail |
IRF2BP2-deficient macrophages worsened atherosclerosis in irradiated low-density lipoprotein recepto... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The chi-square test and multivariable logistic regression analysis with adjustment for covariates re... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: t... | DisGeNET | Detail |
APOE genotype, along with other biomarkers, may be used in the future to assist nurses in identifyin... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs10675722 dbSNP
- Genome
- hg19
- Position
- chr19:45,409,053-45,412,650
- Variant Type
- snv
Genome browser